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ABSTRACT
Background and Objectives: The pathophysiology of post-operative pneumonia
following lung resection is poorly understood despite it being the most common
complication which may lead to death. The role of the acute inflammatory response
following lung resection, in particular innate immune cells, was investigated and used to
identify biomarkers for post-operative pneumonia. Comparison of inflammatory
responses to resection undertaken by video-assisted thorascopic surgery (VATS) and
thoracotomy was also evaluated.
Methods: Patients undergoing lung resection for suspected bronchogenic carcinoma
were recruited. Objective pre-defined criteria were used to diagnose pneumonia.
Bronchoalveolar lavage (BAL) was conducted in the contra-lateral lung pre- and post¬
operatively to measure cellular composition and cytokines. Blood was sampled pre-
operatively and 6-, 24- and 48-hours post-operatively primarily to assess neutrophil
phagocytic capacity, monocyte subsets, monocyte cytokine responses to
lipopolysaccharide (LPS) stimulation and serum cytokine responses. Exhaled nitric
oxide (eNO) was also measured at these time points. Patient groups were compared
using paired or student t-tests together with ANOVA/ANCOVA modelling. The
predictive strength of the biomarkers identified was tested.
Results: 40 patients were recruited. 26 patients (65%) underwent major lung resection
using VATS and 14 (35%) thoracotomy. There was a post-operative blood monocytosis
(p<0.0005) with an absolute expansion of classical and intermediate monocytes
(p=0.001) and a relative fall in non-classical monocytes (p<0.005). Post-operatively
blood monocytes became more pro-inflammatory with an overall significant increase in
IL-8 (p=0.034) and TNF-a (p=0.028) together with an increase in IL-6 (p=0.028) and
IL-10 by 48 hours (p=0.010). VATS was associated with a smaller release of IL-10 only
(p=0.011). There was a general trend towards post-operative reduction in neutrophil
phagocytosis of zymosan (in suspension) on ANOVA modelling (p=0.047). Lung
2
resection led to an increase in serum cytokines IL-6, IL-8 and IL-10 which peaked at
24hrs before falling (p<0.0005). ANOVA modelling confirmed significantly lower
levels of serum cytokines in VATS patients compared with thoracotomy (p=0.026 for
IL-6, p=0.018 for IL-8 p=0.047 for IL-10). No significant post-operative change was
found for IL-ip, TNF-a and IL-12p70 (p>0.05). Bronchoalveolar lavage fluid (BALF)
and blood samples demonstrated a relative post-operative leucocytosis due principally
to neutrophilia. A relative blood lymphopenia and thrombocytopenia developed post¬
operatively (p<0.0005). VATS was associated with a lower fall in serum albumin
(p=0.001). BALF from the non-operated lung became more pro-inflammatory
immediately post-operatively with an increase in IL-6 (p<0.0005), IL-8 (p=0.017), IL-
10 (p=0.018) and IL-ip (p=0.002). eNO tended to fall post-operatively which reached
significance at 48 hrs (p=0.029).
14 patients developed pneumonia. Pre-operatively, a blood neutrophil count above
5.04x109/L had a relative risk (RR) for pneumonia of 3.3 (95% confidence interval
(CI95) 1.1-10.1), and a BAL cell count of greater than 1.04xl05/ml had a RR of 3.4 (CI95
1.3-9.0), whilst LPS-stimulated monocyte secretion of IL-12 of less than 0.15 pg/ml/pg
protein had a RR of 3.0 (CI951.2-7.3). At 24 hours post-operatively, LPS-stimulated
release from monocytes of IL-10 greater than 1.99 pg/ml/pg protein (RR 4.1, CI95 1.3-
12.3) and IL-6 greater than 414 pg/ml/pg protein (RR 3.1, CI95 1.2-8.1) were predictive
of pneumonia.
Conclusion: Lung resection is associated with significant early pro- and anti¬
inflammatory responses. VATS resection invoked significantly lower levels of serum
cytokines and albumin changes compared with thoracotomy suggesting VATS
lobectomy should be the surgical treatment strategy of choice for early stage lung
cancer. No difference in neutrophil function or monocyte function was however
observed between the surgical groups. Clinical benefits of this reduced inflammation
need to be evaluated in a larger cohort of patients. Relative pre-operative leucocytosis in
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blood and BAL together with monocyte hyper-responsiveness in the early post¬
operative period is associated with the development of pneumonia. These findings
warrant further investigation for their predictive power in accurately identifying post¬
operative pneumonia. Ultimately, they may be incorporated into a risk stratification
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I - INTRODUCTION
Despite the overall incidence of lung cancer falling in recent decades in the United
Kingdom (UK), following the decline in smoking, it remains the second commonest
cancer diagnosed in men after prostate cancer and third in women after breast and
colorectal cancer (Cancer Research UK, 2009). In 2009 there were 41,428 new cases
diagnosed in the UK, 56% of which were in men. However, in Scotland alone lung
cancer remains the most commonly diagnosed cancer. Indeed, the incidence in Scotland
is amongst the highest in the world, a position attributed to previous industrial asbestos
exposure and the remaining high prevalence of smoking. Lung cancer continues to be
the leading cause of cancer death in the UK accounting for 24% of all male cancer
deaths and 21% of all female deaths in 2010 (Cancer Research UK, 2010). It is also the
leading cause of cancer death worldwide (Jemel et al., 2011).
Lobectomy is the optimal curative strategy for patients with stage I and II non-small cell
lung cancer (NSCLC) (NICE Clinical Guideline 121, 2011). It confers a five-year
survival benefit, which for stage I NSCLC is in the region of 78% (Walker et al., 2003).
Traditionally lung resection has involved a large incision via a thoracotomy with
exposure gained through the insertion of a retractor between rib spaces and rib
spreading. Since the early 1990s minimally invasive techniques have been developed
for lobectomy via video-assisted thoracoscopic surgery (VATS) (Walker, 1999). This
avoids rib spreading thereby reducing post-operative pain and is associated with faster
post-operative recovery together with a reduced post-operative inflammatory response
(Nagahiro et al., 2001 and Craig SR et al., 2001).
Although peri-operative mortality and morbidity have fallen in recent decades
(Ferguson et al., 2008), major lung resection, via VATS or thoracotomy, continues to
represent a significant risk for the patient. The UK national average in-patient mortality
rate for malignant lung resection is in the order of 2% for lobectomy/bilobectomy and
6.5% for pneumonectomy (SCTS, 2010). The most common complication post-
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operatively is lower respiratory tract infection (LRTI). The exact incidence varies
considerably between surgical series, both prospective and retrospective, with values
ranging from 2-40% (Schussler et al., 2006). The variable incidence probably reflects
the characteristics of the patients, extent of resection, antibiotic prophylaxis and patient
management. Moreover, the criteria used to define post-operative pneumonia vary
considerably between surgical series.
Post-operative pneumonia is associated with an increased length and cost of hospital
stay and may lead to respiratory failure, death or the development of acute lung injury
(ALI) or the more severe form acute respiratory distress syndrome (ARDS) (Uramato et
al., 2001 and Baudouin, 2003). Both ALI and ARDS are characterised by bilateral
pulmonary infiltrates in the absence of cardiac failure with severe hypoxia (Bernard et
al., 1994).
Clinical Risk Factors for Post-Operative Pneumonia
Surprisingly little is understood about the aetiology of pneumonia following lung
resection. A number of retrospective clinical studies have been published identifying
risk factors for post-operative pneumonia. One of the earliest retrospective papers
identified the diffusing capacity of the lung for carbon monoxide (DLCO) to predict
mortality and was the sole predictor of pulmonary complications out of 38 pre-operative
and intra-operative risk factors examined (Ferguson et al., 1988). A more recent study
by the same group identified post-operative predicted DLCO to be the single strongest
predictor of pulmonary morbidity and mortality in patients with and without chronic
obstructive pulmonary disease (COPD) (Ferguson et al., 2008). However, a recent study
concluded that DLCO and PFTs (Pulmonary function tests) in general have no role in
determining pulmonary complications after VATS lobectomy (Berry et al., 2010).
One further study of 242 patients undergoing pneumonectomy for lung cancer sought to
identify independent risk factors for the development of pulmonary complications
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(Algar et al., 2003). Univariate analysis identified increased age, COPD, heart disease,
no previous record of chest physiotherapy, poor post-operative predicted forced
expiratory volume in one second (FEVi) and prolonged anaesthetic time as independent
risk factors for pulmonary complications. In a multiple logistic regression model,
prolonged anaesthetic time, poor post-operative predicted FEVi, heart disease, no
previous chest physiotherapy and COPD were found to be independent risk factors for
pulmonary complications.
A recent retrospective study utilising The Society of Thoracic Surgeons General
Thoracic Surgery Database identified predictors of death and major morbidity in 1,267
patients undergoing pneumonectomy (Shapiro et al., 2010). Age >65, male sex,
congestive cardiac failure, FEVi <60% predicted, benign lung disease and extra-pleural
pneumonectomy were independent risk factors for major morbidity. Chemoradiotherapy
was also a risk factor in lung cancer patients.
Indeed, a number of scoring systems have been published in order to predict in-hospital
mortality following general thoracic surgery based on clinical variables (Berrisford et
al., 2005 and Falcoz et al., 2007). The system of Falcoz et al., termed 'Thoracoscore', is
gaining some acceptance and is currently recommended in the British Thoracic Society
(BTS) guidelines for pre-operative assessment in lung cancer patients (Lim et al., 2010).
Age, gender, American Society of Anaesthesiologists (ASA) Score, performance status,
dyspnoea score, priorty of surgery, procedure class, diagnostic group and co-morbidity
are used to predict in-hospital mortality for all thoracic surgery procedures. The
accuracy and usefulness of the scoring has however been questioned by a recent paper
in patients following lung resection (Bradley et al., 2012). Further, many of these




One focus of basic scientific research has been airway colonisation with pathogenic
microorganisms and the development of post-operative pneumonia. It is well
established that up to a third of smokers and patients with COPD have bacterial
colonisation of the lower airways with potentially pathogenic microorganisms (Soler et
al., 1999). Colonisation patterns do not differ markedly in lung cancer patients from
COPD patients, many of whom have COPD (D'Journo et al., 2011). However, in the
specific instance of an obstructing bronchial carcinoma, Gram negative bacilli and
anaerobes may be found distal to the obstruction (Liaw et al, 1994). Upper respiratory
tract colonisation has been shown to be significantly higher in lung cancer patients
(59.1%) compared to patients without malignancy (37.3%) and healthy volunteers
(37.8%) (Hirakata et al., 1997).
Despite the undoubted airway colonisation in a significant proportion of lung cancer
patients, associating this with post-operative infection has been controversial. A number
of studies have concluded that airway colonisation is a significant independent risk
factor for post-operative pneumonia (Wansbrough-Jones et al., 1991 and Schussler et
al., 2006). Others could find no link (Ioanas et al, 2002). A meta-analysis on the issue
was recently published involving 7 prospective studies including 1083 patients and
concluded there was reasonable evidence for a link (D'Journo et al., 2011). Matching
the actual microbiological organisms found pre- and post-operatively is also
inconsistent. Some of the discrepancy may relate to sampling methods for microbiology
which cannot represent all the distal airways of a particular patient and may miss
specific areas of colonisation. Thus, while it is apparent that there is an association




The clinical and microbiological factors mentioned above together with post-operative
pain requiring opiate analgesia, poor cough and failure to clear airway secretions may
predispose patients to infection. Pre-operative nutritional status has also been linked to
post-operative complications (Jagoe et al., 2001). All of these factors however need to
be seen in the context of an underlying acute inflammatory response to the trauma of
surgery.
One of the earliest studies linking inflammation and post-operative outcome reported
the use of C-reactive protein (CRP) in predicting post-pneumonectomy empyema in a
cohort of 151 patients (Icard et al., 1993). Amar and colleagues examined a number of
markers of inflammation peri-operatively and related these to major post-operative
complications, not just respiratory, in 153 patients undergoing lung resection or
exploratory thoracotomy alone (Amar et al., 2007). A strong association was found for
high pre-operative serum CRP (area under the curve (AUC) 0.86), low albumin (AUC
0.86) and high interleukin-6 (IL)-6 (AUC 0.79)). This suggested pre-operative sub¬
clinical inflammation is likely to be important in the pathogenesis of major post¬
operative complications.
Further, the individual patient inflammatory response to the trauma of surgery may
predict for post-operative complications. Shaw et al. examined polymorphisms in key
inflammatory alleles, IL-6 and TNF-a, in 155 patients (Shaw et al., 2005). They found
that pro-inflammatory genotypes predicted for post-operative complications,
particularly if homozygous for the alleles. In a multi-variate analysis, they found that
cardiovascular disease, IL-6 genotype and TNF-a genotype were independently
predictive of complications, with an area under the curve of 0.765 for the entire model.
Although serum levels of the cytokines were not measured peri-operatively this was an
intriguing study into inflammation as a cause of post-operative morbidity in thoracic
surgery patients.
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Indeed, profound acute inflammation may lead to a systemic inflammatory response
syndrome (SIRS) that can result in organ dysfunction and ultimately death (Bone,
1996). SIRS however also invokes a counter response termed compensatory anti¬
inflammatory response syndrome (CARS) in order to restore homeostasis. Imbalance
between these two responses may be harmful. Prevalence of CARS may lead to immune
anergy and vulnerability to infection.
Neutrophils are the key cell type in the acute inflammatory response. They are rapidly
recruited to sites of infection and tissue injury where they phagocytose and destroy
invading pathogens. Studies in non-surgical critically-ill patients have demonstrated
dysfunction of peripheral blood neutrophil phagocytosis (Simms et al., 1994 and
Kaufmann et al., 2006). Subsequent work has shown this to be related to complement
activation, specifically complement factor 5a (C5a), which inhibited RhoA activation
preventing actin polymerisation (Conway Morris 2009 and 2011). From a cohort of 60
critically-ill patients, C5a-mediated neutrophil dysfunction was a strong predictor of
nosocomial infection. Whether neutrophil dysfunction occurs after lung resection, and
its relation to post-operative complications, has not been studied to date.
Another key cell in the innate immune response is the monocyte. Monocytes circulate in
the peripheral blood for a few days after leaving the bone marrow before migrating into
tissue to eventually become dendritic cells or macrophages. Their role includes immune
defense and tissue repair (Ziegler-Heitbrock et al., 2010). They produce a range of
cytokines, activate T and B lymphocytes and process and present antigen (Ziegler-
Heitbrock, 2007). Three main subsets of monocyte have been identified in humans, that
is, classical (CD14++, CD 16"), intermediate (CD14"1"1", CD16+) and non-classical (CD14+,
CD16"1-1"). Classical monocytes form the majority of circulating monocytes with non-
classical monocytes only representing up to 20% of the circulating pool. Intermediate
monocytes are thought to be a precursor to non-classical cells in that their pool expands
in infection before expansion occurs in the non-classical pool.
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Monocyte deactivation has been described in sepsis and is associated with a much
higher mortality (Docke et ah, 1997). This deactivation is characterised by markedly
reduced HLA-DR expression with a reduced antigen-presenting capacity and a
profound reduction of the ability to produce lipopolysaccharide (LPS)-induced tumour
necrosis factor alpha (TNF-a) in vitro. Monocyte counts and function have been
analysed following major cardiac surgery involving use of the extra-corporeal
cardiopulmonary bypass circuit (Franke et ah, 2009). A monocytosis was reported on
day one but the monocyte function was impaired, demonstrated by a reduced capacity to
synthesise IL-12 and TNF-a, and lower HLA-DR expression. Cytokine-producing
capacity returned to normal on day three but the suppression of HLA-DR persisted.
Similar monocyte immunosuppression has been found in trauma patients admitted to a
trauma centre, the duration of which reflected the severity of trauma sustained (Wutzler
et ah, 2009). Few studies have been published on monocyte changes post-lung
resection. Nosotti et ah found lower HLA-DR expression in lung cancer patients pre-
operatively and short-term changes in subsets after lobectomy via thoracotomy which
returned to normal on day 30. However, the first post-operative sample was taken on
day 5 missing many of the potentially key inflammatory changes. Moreover, actual
monocyte function was not assessed, nor were the classical markers defining monocyte
subsets.
Inflammatory changes at a local pulmonary level are poorly characterised after lung
resection with scarce studies published. One-lung ventilation (OLV) of the non-
operated lung is mandatory during lung resection. This may lead to a form of lung
injury in itself through a number of proposed mechanisms (Baudouin, 2003). During
collapse of the operated lung, blood flow is reduced which may lead to a form of
ischaemia-reperfusion injury once dual lung ventilation is resumed. The consequent
increased flow of blood to the contralateral lung intra-operatively may lead to
pulmonary capillary stress and may produce capillary injury. The contralateral lung may
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also suffer from ventilator-induced lung injury depending on tidal volumes used in
addition to hyperoxia and the generation of reactive oxygen species (ROS).
Bronchoalveolar lavage has rarely been used to characterise these inflammatory
processes after lung resection. One study involved 15 patients (Breunig et al., 2011). IL-
6, IL-1 receptor antagonist (IL-1 RA) and growth-regulated peptide alpha (GRO-a)
were measured after induction of anaesthesia and after lung resection in BALF from
both lungs as well as pleural fluid and blood. A significant increase in IL-6 and IL-1 RA
was found but not GRO-a in both lungs after surgery. This suggests the initiation of
both pro- and anti-inflammatory responses at the time of surgery. IL-6 was higher in the
operated lung post-operatively but no difference was observed between the lungs for IL-
1RA and GRO-a.
More information on the impact of OLV during surgery can be gleaned from
oesophagectomy patients. Cree et al. showed higher levels of IL-8 in BALF than
peripheral blood in 21 patients but no difference between collapsed and ventilated lungs
(Cree et ah, 2004). Importantly however the collapsed and ventilated samples were
taken from two different groups of patients. Zingg et al. found higher levels of IL-6, IL-
8 and IL-1 RA in the ventilated lung prior to extubation when conducting BAL in both
lungs of the same patient (Zingg et al., 2010). Clearly, inflammatory changes occur in
the ventilated, comparatively healthy lung following OLV which is of considerable
interest to evaluate further for lung resection patients through BAL.
Nitric oxide is a diatomic molecule formed from oxygen and nitrogen. It is a soluble gas
containing an unpaired electron, making it highly reactive. It has a short half-life and is
able to freely move across cell membranes without specific transporters (Masri F,
2010). It is produced throughout the body at three principal sites; the macrophage, the
airway and vascular endothelium. It is produced by three isoforms of nitric oxide
synthase (NOS); inducible NOS (NOS2), neuronal (NOS1) and endothelial (NOS3)
(Kobzik L, 2009). Nitric oxide production may be increased by upregulation of
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inducible nitric oxide synthase (iNOS). Its role is complex but the balance of evidence
suggests that it plays a role in innate immune defense in humans. It is also a vaso- and
bronchodilator and contributes to co-ordination of ventilation/perfusion (Marczin et al.,
1997). Its vasodilator properties on endothelium are the principal reason for inhaled
nitric oxide use in managing established ARDS and persistent pulmonary hypertension
of neonates (Adler et ah, 2009).
Several studies have demonstrated increased levels of nitric oxide in the exhaled breath
of patients with inflammatory lung diseases. Exhaled nitric oxide levels are increased
in asthmatic patients, whom suffer a chronic eosinophilic inflammatory process, which
decrease with anti-inflammatory therapy such as corticosteroids (Barnes et ah, 1995 and
Yates et ah, 1995). Conversely, in established ARDS, levels of exhaled nitric oxide are
reduced (Brett et ah, 1998) as well as following lung transplantation (Marczin et ah,
1997). The possible reason for this reduction is down regulation of constitutive or type I
nitric oxide synthase (NOS) and an inability to produce type II NOS or iNOS. Further,
eNO may react with highly reactive molecules such as superoxide forming
peroxynitrite.
Marczin et ah noted that no change in exhaled nitric oxide was associated with a good
clinical outcome whereas a reduction was associated with morbidity and mortality after
transplantation surgery in a small cohort of patients (Marczin et ah, 1997). Conversely,
increased levels of eNO after haematopoietic stem cell transplantation appear to be a
marker for pulmonary complications in children (Fazekas et ah, 2012). Few studies
have examined exhaled nitric oxide peri-operatively after lung resection. Moreover, by
using variable flow rates of exhaled breath to measure exhaled nitric oxide, alveolar and
upper airway contributions to total exhaled nitric oxide can be calculated using the two-
compartment model of airway dynamics (Pietropaoli et ah, 1999).
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Hypotheses
This study sought to determine whether respiratory complications after lung resection
for suspected lung cancer could be related to peri-operative changes in innate immune
function. Two fundamental hypotheses were proposed:-
(i) An exaggerated local pulmonary and systemic inflammatory response early in
the couise of surgery predicts for respiratory complications such as pneumonia;
(ii) Impaired cellular innate immune responses may predispose patients to acquiring
post-operative pneumonia.
Study Aims
In order to test these hypotheses an in-depth study ofpulmonary and systemic innate
immune responses following lung resection for lung cancer was devised relating these
changes to the type of surgery undertaken and post-operative complications. Such a
comprehensive study has not been undertaken before. The specific aims were:-
(i) To determine baseline and post-operative changes in pulmonary cytokines,
total protein and differential cell count using bronchoalveolar lavage from
the comparatively healthy, non-operated lung;
(ii) To measure baseline and serial trends in exhaled nitric oxide;
(iii) To determine baseline and serial changes in neutrophil phagocytic capacity;
(iv) To evaluate baseline and serial changes in monocyte subsets and monocyte
cytokine responsiveness to LPS stimulation;
(v) To determine baseline and post-operative trends in leucocyte and differential
cell count;
(vi) To compare baseline innate immunity and inflammatory measurements of
pre-operative lung cancer resection patients with that of a group of healthy
control patients of a similar age and mixed gender;
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(vii) To compare innate immunity and inflammatory responses ofpatients
undergoing lung resection via VATS and thoracotomy;
(viii) To accurately determine the rate of post-operative pneumonia, acute lung
injury and acute respiratory distress syndrome using prospectively defined
criteria;
(ix) To establish which of the above biological indices best predict for the
development of post-operative pulmonary complications after major lung
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Patient Recruitment
Patients referred for Thoracic Surgery at The Royal Infirmary of Edinburgh with proven
or clinically suspected lung cancer were eligible for this study. The Edinburgh Thoracic
Surgery unit is a tertiary referral centre and one of the largest units in the UK. All
patients referred for surgical resection in Edinburgh undergo bronchoscopy and cervical
mediastinoscopy routinely before being offered surgical resection. The aim is to identify
N2 disease which, by definition, is incurable by surgery alone (Nice Clinical Guideline
121) and may not have been identified on staging investigations such as Positron
Emission Tomography-Computed Tomography (PET-CT) or Fine Needle Aspiration-
Endobronchial Ultrasound (FNA-EBUS) (Carnochan et ah, 2009).
It was ahead of surgical staging that patients under the care of a single Consultant
Cardiothoracic Surgeon, Mr. William S. Walker, were approached to take part in the
study. Participation was entirely voluntary with no financial incentive offered. Written
informed consent was obtained from interested patients and a confidential record kept
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of their personal details. Patients were excluded from the study if there was evidence of
metastatic disease on routine pre-operative staging, if mediastinoscopy staging revealed
tumour involvement in lymph nodes or at any point on the request of the patient or
Consultant Surgeon. A total of 53 patients were eligible and consented to take part in
the study however 13 patients were excluded leaving a total of 40 patients in the study.
The reasons for exclusion were that 7 patients had tumour positive mediastinoscopy, 2
patients withdrew post-operatively as they did not wish to undergo the tests required, 1
patient was excluded because pneumonectomy was required prior to ethical approval
for inclusion of pneumonectomy patients being obtained, 1 patient was deemed unfit for
resection after staging bronchoscopy and mediastinoscopy and 2 patients were excluded
due to the scheduling of lung resection surgery and the inability to process more than 2
patient resections per week.
Control Patient Recruitment
Ten patients of mixed gender but a similar age range to the study population were
recruited to act as a control group for the blood and exhaled nitric oxide tests. They
were identified with the co-operation of Dr. Hamish Reid, General Practitioner, from
the Penicuik Health Centre patient database and invited to take part in the research
study. Each patient voluntarily attended The Royal Infirmary of Edinburgh Thoracic
Surgery ward for this purpose where written, informed consent was obtained. Patients
were eligible if they were considered generally healthy without significant illness,
especially current or previous lung cancer diagnosis or treatment, or ongoing cancer
surveillance.
Surgical Resection
Surgical resection was performed when possible via video-assisted thoracoscopic
surgery (VATS) lobectomy (Walker, 1999) or via postero-lateral thoracotomy (Shields,
2004). For the VATS approach the surgeon utilised an endoscopic hilar dissection
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technique under single-lung anaesthesia. An incision (approximately 5cm in length) was
created in the lateral sub-mammary area as a utility port for the passage of large
instruments and staplers. This allowed prompt lung collapse and the identification of the
most appropriate location for a posterior videothoracoscope port. This provides an
excellent view of the thoracic cavity and major fissure similar to the aspect presented to
the surgeon at a conventional thoracotomy. A single inferior port was also created
which was used at the end of the procedure for the chest drain. Conversion to open
thoracotomy was effected by linking the posterior videothoracoscope port and anterior
sub-mammary incision which created a virtually identical thoracotomy to that utilised in
the standard open technique.
Postero-lateral thoracotomy involved a larger incision with division of the latissimus
dorsi muscle and posterior elements of the serratus muscle preserving serratus anterior.
Post-Operative Analgesia
The standard protocol for the unit was intra-operative insertion of a paravertebral
catheter for continuous post-operative local anaesthetic administration and intravenous
opiate via patient-controlled analgesia (PCA) for the first 24 to 48 hours. Thereafter,
patients were converted to oral paracetamol, dihydrocodeine and/or tramadol and/or
nefopam.
Clinical Details
Patient demographics, co-morbidities, risk factors, results of investigations and details
of surgery and clinical course were obtained from the NHS (National Health Service)
confidential medical record and/or direct patient history. These data were obtained with
explicit consent and stored electronically without patient identifiable information.
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Outcomes
Post-operative trends in biomarkers were analysed for all patients. Patients were then
grouped into those with clinical pneumonia and those without clinical pneumonia for
analysis. Comparative analysis was also performed of patients undergoing lung
resection via VATS or postero-lateral thoracotomy.
Clinical Definitions
Lower respiratory tract infection (LRTI) was defined as new alveolar infiltrates on the
chest x-ray (CXR) at 72hrs plus two from three of the following: -
1. Temperature >38.0°C or <35.5°C
2. White blood cell count (WBC) >11.0 or <4.0xl09/l (on NHS Full Blood Count
Analysis)
3. Positive sputum culture.
The CXR at 72hrs was formally reported by a Consultant Radiologist specialising in
chest radiology.
Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) were
defined according to the universally applied American-European consensus (Bernard et
al., 1994) which is described as: -
1. Acute onset
2. Bilateral infiltrates on CXR
3. Pa02/FiC>2 ratio <300mmHg for ALI and <200mmHg for ARDS
4. No clinical evidence of left atrial hypertension (or pulmonary artery wedge
pressure < 18mmHg if measured).
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Summary of Samples Obtained
Samples were obtained from patients pre-operatively and at various time points post¬
operatively to compare baseline parameters and elucidate temporal changes following
surgery. Patients were requested to have venepuncture (30mls of blood), breath tests for
measurement of exhaled nitric oxide, bronchoalveolar lavage (BAL) and an infection
screen consisting of a CXR, blood culture (20mls of blood), sputum culture, mid-stream























Blood X X X X




Table 2.1 Overview of the Timing of Patient Sampling.
The blood sample at 24hrs also involved arterial blood gas analysis which was usually
taken from the arterial pressure monitoring line, or otherwise by radial artery puncture.
Obtaining BAL fluid before surgery and repeating the procedure on the same patient
after surgical trauma has not been performed before and provides an ideal opportunity
to evaluate the lungs' inflammatory response to surgical trauma.
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Blood Preparation
Blood was prepared to separate serum from erythrocytes and enable isolation of
granulocytes and mononuclear cells using dextran sedimentation and percoll gradient
extraction (Haslett et al., 1985). The blood was sampled in the hospital ward and
immediately transferred into a 50ml Becton Dickinson (BD) Falcon tube containing
3mls of Sodium Citrate and transported to the research laboratory. This was adjacent to
the hospital at The Queen's Medical Research Institute. It was immediately centrifuged
at 350g for 20 minutes with acceleration of 5, brake 0 and temperature 20°C.
All blood preparation was undertaken in a laminar flow hood. The platelet rich plasma
(PRP) layer was removed from the centrifuged blood using a plastic pipette, with care
taken to avoid disturbing the layers beneath, and transferred into 10ml glass vial tubes,
adding 220pl of Calcium Chloride per 1 Omls. This was left for 1 hour in a water bath at
37°C. The platelet plug was then removed by passage through a BD microfilter leaving
the serum. 1ml aliquots of serum were placed into 1.5ml Eppendorf tubes and frozen at
-80°C for later analysis. Typically 10 aliquots were frozen at each time point with 1ml
of serum retained for use in the same-day experiments.
While the PRP was in the water bath, 6mls of 6% Dextran was added to the erythrocyte
layer and topped up to the 50ml mark with 0.9% Sodium Chloride. The tube was
inverted a few times to mix. Air bubbles were removed using a plastic pipette. The tube
was left to stand for a maximum of 20 minutes or until sedimentation had taken place.
Whilst awaiting sedimentation, Percoll gradients were prepared. 3mls of lOx phosphate
buffered saline (PBS) was added to 27mls of Percoll to make up Percoll Stock. From
the Percoll Stock, three gradients were prepared in 15ml BD Falcon tubes as follows: -
81% - 8.1 mis of Percoll stock plus 1.9mls PBS without calcium and magnesium
68% - 6.8mls of Percoll stock plus 3.2mls PBS without calcium and magnesium
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55% - 5.5mls of Percoll stock plus 4.5mls PBS without calcium and magnesium.
The gradients were layered carefully into a 15ml BD Falcon Tube. 3mls of the 81%
gradient was layered first followed by 3mls of the 68% solution.
Once sedimentation had taken place, the top layer was carefully removed and
transferred to another 50ml BD Falcon tube. This was then topped up to 50mls using
0.9% Sodium Chloride and centrifuged at 350g for 6 minutes, acceleration 9, brake 9
and temperature 20°C. The erythrocytes were discarded. The top layer was discarded
and the cell pellet re-suspended in 3mls of the 55% solution. This was carefully pipetted
onto the other layered gradients. The layered gradients tube was then centrifuged at
700g for 20 minutes, acceleration 0, brake 0 and temperature 20°C.
Excess fluid was subsequently removed from above the mononuclear layer using a
plastic pastette. The mononuclear layer could then be carefully transferred into another
50ml BD Falcon tube. Excess fluid was next removed from above the granulocyte layer
allowing the granulocyte layer to be transferred into a separate 50ml BD Falcon tube.
Each tube was then topped up to 50mls with PBS and centrifuged at 350g for 6 minutes,
acceleration 5 brake 5 and temperature 4°C. The excess fluid was removed from the
pellet in each tube and then re-suspended in PBS to the 30ml mark. A NucleoCount®
was then undertaken (Chemometec, Denmark). For this, 50pl of cells were mixed with
50pi of Reagent A and 50pi of Reagent B. This mixture was aspirated into the chamber
of the NucleoCassette and placed in the NucleoCounter and the cell concentrations
recorded.
As a quality control measure, cytospin preparations were performed using 90pl of cell
suspensions at a concentration of lxl06/ml plus lOpl serum and the slide spun at
3500rpm for 5 minutes. The slide was then air dried and a Giemsa stain performed
before viewing under light microscopy. In addition, 300pl of lxl06/ml cell solution was
added to flow cytometry tubes plus 300pl of FACSLyse (BD, EIK) for later flow
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cytometry analysis (please refer to flow cytometry section for further details) (Figure
2.1).
The mononuclear and granulocyte tubes were then topped up to 50mls with PBS and
spun again at 350g for 6 minutes at acceleration 5, brake 5 and temperature 4°C. The
cells were finally re-suspended at the desired concentrations in Iscove's Modified
Dulbecco's Medium (IMDM) and kept on ice prior to use within a few hours.
Suspended Neutrophil Phagocytosis
Patient neutrophil phagocytosis was evaluated by flow cytometry analysis of
neutrophils exposed to fluorescently labelled Escherichia coli and Zymosan A (from
Saccharomyces cerevisiae). Patient neutrophils (prepared as per the blood preparation
section) were re-suspended at 10xl06/ml in IMDM. 4pl ofEscherichia coli (K-12
strain) Bioparticles® pre-conjugated with the fluorophore Alexa Fluor® 488
(Invitrogen, UK) was added to an equal volume of autologous patient serum and placed
in an incubator at 37°C, 5% CO2 for 30 minutes to enable opsonisation. 11 pi of
Zymosan A (from Saccharomyces cerevisiae) Bioparticles® pre-conjugated with Alexa
Fluor® 594 (Invitrogen, UK) was also mixed with 1 lpl serum and placed in the
incubator for 30 minutes. At the first time point 7 conditions were prepared: -
1. E. coli and serum
2. Zymosan A and serum
3. An unstained tube
4. E. coli and no serum (negative control)
5. E. coli and ice cold serum (negative control)
6. Zymosan A and no-serum (negative control)
7. Zymosan A and ice cold serum (negative control).
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At subsequent time points only the fluorophore and serum plus fluorophore and no
serum were run. A total volume of 1 ml of IMDM was added to each tube with 10%
patient serum as indicated. Serum and medium were kept on ice for the cold incubation.
5x105 neutrophils (50pl) were added to each tube. 20pl Zymosan A/serum mix was
added to the appropriate tube (cold and warm) and lOpl to the no serum tube. Similarly
for E. coli, 2pi E. coli/serum mix was added to the serum tube and lpl to the no serum
added tube. The tubes were then incubated at 37°C or at 4°C on ice as appropriate for
30 minutes. The fluorophore concentration and duration of experiment was decided
upon after a dose and time course trial experiment.
Following incubation, lOOpl of 0.4% Trypan Blue was added to each tube to dull any
surface bound but not phagocytosed fluorescence probe. Each eppendorf tube was then
topped up with PBS and centrifuged at 350g for 4 minutes at 4°C. The supernatant was
removed by careful pipetting and the pellet was washed twice more with PBS. The
pellet was then resuspended in 300pl FACS™ Lyse solution, transferred to flow
cytometry tubes and stored in foil in the cold room until flow cytometry analysis (within
7 days).
A template was created on the flow cytometer (BD Special Order LSR Fortessa) to
enable consistent collection of data. The granulocytes were gated on according to size
and granularity (Forward Scatter (FSC) and Side Scatter (SSC) respectively).
Fluorescence was then measured on the gated cells using channels B 530/30 and YG
610/20 for E. coli and Zymosan respectively. The data were subsequently analysed
using FlowJo Software (Version 7.6.3) (TreeStar Inc, USA) with the unstained sample
used as the basis of the gating for positive phagocytosis.
Plated Neutrophil Phagocytosis
Light microscopy of neutrophil phagocytosis of Zymosan (from Saccharomyces
cerevisiae) was used as a second method of assessing neutrophil phagocytosis. 250pl
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Zymosan (2mg/ml) was added to an equal volume of autologous serum. On a 24-well
Costar® plate (Corning, Amsterdam), six wells were used consisting of the following in
duplicate; neutrophils alone, neutrophils/zymosan with no serum and
neutrophils/zymosan/serum. 1ml IMDM was added with 10% serum as indicated. 5xl05
neutrophils (50pl) were added to each well. The plate and zymosan/serum mix were
incubated at 37°C 5% C02 for 30 minutes. Cell adherence to the plate was then
confirmed with light microscopy. lOpl Zymosan/serum mix or 5pi Zymosan alone was
subsequently added to the appropriate wells and the plate replaced in the incubator for
30 minutes. The culture supernatant was then aspirated from each well and the wells
gently washed twice with IMDM. After air drying, Giemsa staining was performed.
Positive phagocytosis was defined as the proportion of neutrophils that had ingested two
or more zymosan particles as determined by light microscopy. A minimum of 200 cells
were counted in each well at two separate positions and the average of the two wells
was calculated.
Monocyte Subset Staining For Flow Cytometry
There are at least three subsets of monocytes in humans; classical CD14++CD16"CCR2+,
non-classical or inflammatory CD14+, CD16"1-1", CXsCRl+, and intermediate CD14t+,
CD16+. All monocytes express variable levels of the Major Histocompatibility Complex
Class II (MHC II) molecule HLA-DR. Evaluation of monocyte subset changes, if any,
following thoracic surgery may further help understanding of the inflammatory
response.
Following blood preparation (described under Blood Preparation) the mononuclear
layer was re-suspended at 2xl06/ml in IMDM. Seven conditions were prepared in BD
glass flow cytometry tubes; Unstained, CD 14, CD 16, CCR2, CX3CRI, HLA-DR and
'Mix'.
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0.5mls of the mononuclear layer (i.e. lxl 06 cells) was added to each tube plus 50pl
mouse serum (Biosera, UK) and left on ice in the cold room for 30 minutes to prevent
non-specific binding. Following incubation, the individual fluorescence conjugated
antibodies were added to the corresponding labelled tubes in the following
concentrations and left for 30 minutes on ice; lpl (0.2pg) PerCP-Cy™5.5 conjugated
mouse igg2a k anti-human CD14 (BD, UK), 0.5pl PE-Cy™7 conjugated mouse IgGl k
anti-human CD 16 (BD, UK), lpl (0.05pg) V450 conjugated mouse IgG2a anti-human
HLA-DR (BD, UK), 5pl Alexa Fluor® 647 conjugated mouse IgG2b anti-Human
CD 192 (CCR2) (BD, UK) and 5pi (0.05pg) FITC conjugated rat IgG2b K anti-Human
CX3CRI (MBL, International Corporation, Mass., USA). All five antibodies were
added to the 'Mix' tube. These concentrations were determined following a titration
experiment to determine the minimum concentration required to achieve saturating
staining based on the manufacturers' recommended volume for flow cytometry as the
maximum.
Following incubation, each tube was washed twice with 1ml PBS and centrifuged at
350g for 5 minutes, brake 5, acceleration 5, temperature 4°C. After the final wash, the
cells were re-suspended in 400pl of FACSLyse. The cells were later analysed with
digital flow cytometry (BD Special Order LSR Fortessa). All seven tubes were used for
the pre-resection time point for each patient however at subsequent time points only an
unstained and mixed tube were run.
A template was created for 5-colour analysis on the digital flow cytometer. Monocytes
were gated on using FSC and SSC properties and each single stain was monitored for








Table 2.2. Fluorescence Conjugated Antibodies with Respective Fluorescence Channel
on the Flow Cytometer for Monocyte Subset Analysis.
Fluorescent 'spill-over' into other channels was manually compensated digitally for
each antibody and the compensation settings applied to all tubes. Subsequent analysis of
the compensated data was performed using FlowJo Software (Version 7.6.3) (TreeStar
Inc, USA). Monocytes were gated on using FSC and SSC properties and those with
positive HLA-DR staining were analysed for CD 14 and CD 16 staining. CX3CRI and
CCR2 staining was used to confirm correct identification of specific sub-populations of
monocytes.
Stimulation of Monocytes with Lipopolysaccharide (LPS)
The remaining mononuclear cells were centrifuged at 350g, brake 5, acceleration 5 and
temperature 4°C for 5 minutes prior to re-suspending in 80pl of buffer (PBS, pH 7.2,
0.5% bovine serum albumin (BSA). 20pl MACS™ CD 14 human microbeads (Miltenyi
Biotec, Germany) were added and the mixture vortexed and left on ice for 15 minutes.
Unbound beads were removed by washing once with 1 ml buffer and centrifuging at
350g, acceleration 5, brake 5 temperature 4°C for 10 minutes. The supernatant was then
carefully aspirated and the cell pellet re-suspended in 500pl of buffer.
The CD14+ cells (i.e. monocytes) were then separated from CD 14" cells by passage
through a magnetic column. The magnet (MiniMACS™ Separator, Miltenyi Biotec,
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Germany) was placed on a metal stand and the separating column (MS Column,
Miltenyi Biotec, Germany) placed in the designated groove in the middle of the magnet.
The column was prepared by adding 500pl of buffer. Once drained, the cells were
added into the column and allowed to slowly drain, collecting the CD 14" cells at the
bottom in a 15ml BD Falcon tube. The column was then washed three times using
500pl of buffer, collecting the contents into the CD 14" tube. The bound CD14+ cells
were then released from the column by removing the magnetic field, adding 1ml of
buffer and immediately plunging the contents into a labelled CD14+ 15ml BD Falcon
Tube. 4mls of buffer was then added to the CD14+ tube and a cell count performed
using the Nucleocounter®. Typically 2-5x106 monocytes were isolated and the cells re-
suspended in IMDM at lxl06/ml.
Monocyte purity was assessed using light microscopy of a cytospin preparation and
flow cytometry. For the cytospin, 90pl of cells was added to 10pi of patient serum and
the slide spun at 350rpm for 5 minutes. The slide was then air dried and a Giemsa stain
performed before viewing under light microscopy.
On a 24-well Costar® (Corning, Amsterdam) flat bottomed cell culture plate, 2 wells
were labelled as monocytes + 0 (pre-operatively only) and 2 wells as monocytes + LPS.
500pl IMDM, 50pl serum and lOOpl of monocytes (100,000 cells) were added to each
well. lOOng of LPS (final concentration 154 ng/ml) from Escherichia coli 0127:B8
(Sigma, UK) was added to the two corresponding wells and incubated at 37°C 5% CO2
for 18 hours. A time course experiment was used to determine this incubation period.
The supernatant was then aspirated from each well and placed into 1.5ml labelled
eppendorf tubes. These tubes were then centrifuged at 350g for 4 minutes at 4°C in a
bench top eppendorf centrifuge. The supernatant was again removed and aliquots frozen
at -80°C in eppendorf tubes together with the plates for later analysis.
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Bronchoalveolar Lavage
Bronchoalveolar lavage (BAL) was performed under general anaesthesia at two time
points using a flexible bronchoscope using a standardised technique as detailed below.
Two BALS were performed in each patient studied unless the patient underwent a
pneumonectomy where a post-operative BAL was avoided to ensure patient safety. The
first was immediately after induction of anaesthesia at the time of the staging
bronchoscopy and mediastinoscopy (ie before surgical trauma) (please refer to table
2.1). The second was after completion of lung resection prior to the patient being
extubated in theatre (ie after surgical trauma). This required the flexible bronchoscope
to be passed through a single lumen endobronchial tube and double lumen tube after the
first and second time points respectively.
The contralateral lung to the culprit lesion was lavaged on both occasions with a
different lobe lavaged each time. The bronchoscopy and lavage was performed by the
Consultant Cardiothoracic Surgeon, Specialist Registrar/Associate Specialist or
Research Fellow using a standardised protocol. Once the bronchoscope was wedged in
a segmental bronchus, 20mls of 0.9% NaCl was injected through the bronchoscope
using a 50ml BD luer lock syringe (representing a bronchiolar sample) and immediately
suctioned and discarded. Then 50mls of 0.9% NaCl was injected and the suctioned
contents collected in a lavage trap. A further three aliquots of 50mls were injected and
again collected in lavage traps. The lavage trap was only changed once nearly full. The
lavage contents were pooled into 50ml BD Falcon tubes and transported immediately to
the research laboratory on ice for processing.
In a laminar flow hood, the BAL fluid was filtered using BD cell strainers (BD, UK).
The strainer was changed when occluded by mucus. The total volume filtered was
recorded. Two lOOpl aliquots of filtered BAL were placed into 1.5ml eppendorf tubes
for cell count enabling the remaining BAL to be centrifuged at 350g, acceleration 5,
brake 5 for 10 minutes at 4°C. Meanwhile, the cell count was performed by taking 50pl
43
of BAL solution and mixing with 50pl of reagent A and B and placing in the
Nuclocounter® as previously described (please refer to Blood Preparation Section).
Following centrifugation, the BAL fluid supernatant was carefully poured into a 50ml
BD Falcon tube. Ten 1ml aliquots were placed into 1.5ml eppendorf tubes and stored in
the freezer at -80°C for later analysis. The cellular pellet was re-suspended in PBS at a
concentration of lxlO6 cells/ml. Two cytospins were then performed as previously
described with 10% serum (please refer to blood preparation section). Once the slides
were air dryed, a Giemsa stain was performed. Under light microscopy a differential
cell count was performed counting at least 200 cells with two different microscopy
fields.
Serum Cytokine Analysis
Serum cytokines were analysed using a commercially available Cytometric Bead Array
(CBA) kit (BD Human Inflammatory Cytokines Kit, UK). This kit uses six bead
populations with distinct fluorescent intensities coated with capture antibodies specific
for IL-8, IL-ip, IL-6, IL-10, TNF-a and IL-12 cytokines. The beads were mixed
together with the samples/standards and the PE-conjugated detection antibodies to form
sandwich complexes. Data were acquired and quantified using the red channel of a flow
cytometer.
Each sample was run in duplicate and a mean calculated for the final patient result. The
kits were stored at 4°C in the cold room until use. Reagents were allowed to warm to
room temperature for 30 minutes before use.
An aliquot of each serum sample was removed from the -80°C freezer and allowed to
thaw thoroughly before use. The samples were run neat. 5pl of each human
inflammatory cytokine capture bead (A1-A6) was used per patient sample allowing for
an additional 9 standard dilutions. The capture beads (A1-A6) were vortexed before
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pipetting the volume required into a 15ml BD Falcon tube. The bead mixture was then
vortexed briefly before centrifuging at 200g for 5 minutes at acceleration 5, brake 5,
temperature 20°C. The supernatant was carefully aspirated and discarded before re-
suspending the pellet in Serum Enhancement Buffer in a volume equal to the volume of
supernatant removed. This was then vortexed thoroughly and incubated in the dark for
30 minutes.
One vial of lyophilized standards was transferred into a 15ml BD Falcon tube and re¬
constituted with 2ml of assay diluent (the 'top' standard). This was allowed to
equilibrate for at least 15 minutes before making dilutions. It was mixed carefully with
a pipette alone to avoid frothing. A further eight 12x75mm BD Falcon glass tubes were
labelled as 1:2, 1:4, 1:8, 1:16, 1:32, 1:64, 1:128, 1:256 and 300pl of assay diluent added
to each. Serial dilution was undertaken by transferring 300pl of the top standard to the
1:2 tube and mixed thoroughly by pipette. Further serial dilutions were conducted by
transferring 300pl from the 1:2 tube to the 1:4 and so on.
The assay itself was performed in multiple Costar® 96-well plates (Corning,
Amsterdam). 25pi of the mixed capture beads was added to each well. 25pi of each
standard was added to the first 10 horizontal wells commencing with the assay diluent
alone working up to the top standard in well 10. 25pl of each sample was then added to
the remaining wells in duplicate. The tubes were incubated for 1.5 hours at room
temperature in the dark. After the pipetting for one plate was complete and incubating,
other plates could be commenced, running a maximum of 5 plates per day.
lml of wash buffer was added to each assay tube and centrifuged at 200g for 5 minutes,
acceleration 5, brake 5 and temperature 20°C. The supernatant was carefully aspirated
and discarded leaving approximately 50pl of solution in each well. 25pl of the PE
detection reagent was added and the plate gently agitated to mix. The plate was then
incubated in the dark at room temperature for a further 1.5 hours.
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Approximately, 15 minutes prior to completion of incubation, the plate reading software
was set-up (BD FACSArray). This machine was equipped with a 488 nm laser capable
of detecting and distinguishing fluorescence emissions at 576 and 670 nm. Set-up
included entering details of the BD kit, number of standards/replicates and plates.
After incubation, 175 pi of wash buffer was added to each well using a multi-channel
pipette and centrifuged at 200g for 5 minutes, acceleration 5, brake 5 and temperature
20°C. The contents were then discarded before re-suspending the bead pellet in 125pi of
wash buffer and analyzing the plates within 3 hours. After the plate reading the
fluorescence of the known standards was used to generate a standard curve for each
cytokine and convert the fluorescence of the patient samples into an individual cytokine
measurement in pg/ml using BD CellQuest™ Software.
Other Cytokine Analysis
The BAL fluid supernatant and LPS-stimulated monocyte supernatant cytokine analysis
was also conducted using the Cytometric Bead Array (CBA) Human Inflammatory
Cytokines Kit (BD) with important modifications as per the manufacturer's instructions.
The capture beads could be simply mixed together without the need for centrifugation
and re-suspension in serum enhancement buffer. Further, when pipetting onto the
Costar® (Corning, Amsterdam) 96-well plates, the PE detection reagent was added
immediately after the capture beads followed immediately by the patient samples. The
plate was then incubated in the dark and room temperature for 3 hours before washing
and re-suspending in 125pl wash buffer for analysis. BAL fluid samples were run neat
in duplicate. The monocyte supernatant cultures were run neat and at 1:50 dilution after
a trial dilution series.
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Bradford Assay
The total protein content of each well of the monocytes stimulated with LPS was
calculated using the Bradford Assay to enable total protein correction of cytokine
results. This is a colorimetric protein assay based on the absorbance shift of the dye
Coomassie Brilliant Blue G-250. Under acidic conditions, the red form of the dye is
converted into its blue form allowing binding to the protein being assayed. Protein
binding stabilises the blue form thus the amount of blue dye present is a proportional
measure of the total protein, estimated using an absorbance reading.
The plates were thawed to room temperature for approximately 30 minutes. 0.5mls of
NaOH was added to each well and a pipette tip used to scratch the surface of each well
to ensure the cell layer was mixed. The plate was then allowed to stand for 10 minutes
before beginning the assay.
A set of 6 standards was used. A stock solution was prepared of lOOmg/ml by adding lg
Bovine Serum Albumin (BSA) to lOmls NaOH. From this stock, a working stock of
1 OOpg/ml was prepared by adding 15pi of lOOmg/ml BSA to 15mls NaOH. The
standards were then prepared as below:
Standard Concentration Volume NaOH Volume lOOpg/ml BSA
Opg/ml lOmls 0ml s
5pg/ml 9.5mls 0.5mls




Table 2.3. Preparation of Standard Concentrations for Bradford Assay.
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In a Costar® 96-well plate (Corning, Amsterdam), 1 OOpl of standards was added to the
initial wells in duplicate. lOOpl of sample was then added to each well with a careful
record kept of the sample ID. This was followed by lOOpl of Bradford Reagent which
changed colour from brown to blue immediately. The results were then read on a plate
reader at 595 nm. The absorbance of the standards vs. their concentration was used to
generate a standard curve enabling calculation of the concentration of the unknown
samples.
BCA Protein Assay Kit
The above kit was used for the colorimetric detection and quantification of total protein
• • +2
in BAL fluid supernatant (Thermo Scientific, UK). It is based on the reduction of Cu
to Cu+1 by protein in an alkaline medium and the colorimetric detection of Cu+1 using a
unique reagent containing bicinchoninic acid (BCA). The purple coloured reaction is
formed by the chelation of 2 molecules of BCA with one cuprous ion and the
absorbance at 562nm is almost linear with increased protein levels over the range 20-
2000pg/ml. A series of dilutions of known concentration are prepared from BSA
enabling the generation of a standard curve. This enabled calculation of the sample
protein concentration.
The kit was removed from cold storage and a set of protein standards were prepared









A 0 300 of Stock 2,000
B 125 375 of Stock 1,500
C 325 325 of Stock 1,000
D 175 175 of Vial B
Dilution
750
E 325 325 of Vial C
Dilution
500
F 325 325 of Vial E
Dilution
250
G 325 325 of Vial F
Dilution
125
H 400 100 of Vial G
Dilution
25
I 400 0 0=Blank
Table 2.4. Preparation of Standard Concentrations for BCA Protein Assay Kit.
The total volume of working reagent (WR) was calculated according to the
manufacturers' guidance (Total volume of WR= (# standards + # unknowns) x (#
replicates) x (200). The WR was prepared by mixing 50 parts of reagent A with 1 part
reagent B.
25pl of each standard and patient sample was pipetted onto a Costar® 96-well plate
(Corning, Amsterdam) in duplicate. 200pl of the WR was added to each well and mixed
thoroughly for 30 seconds on a plate shaker. The plate was covered and incubated at
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37°C for 30 minutes. The plate was then cooled and absorbance measured on a plate
reader at 562nm.
Exhaled Nitric Oxide
Fractional Exhaled Nitric Oxide (FENO) was measured from patients pre-operatively
and at 6, 24 and 48 hrs post-operatively using a chemilumenescent analyser (Niox®
Flex, Aerocrine AB; Smidesvagen, Sweden) and a smaller portable electrochemical
sensor (Niox® Mino Aerocrine AB; Smidesvagen, Sweden). All recordings were made
at the patient's bedside. The chemiluminescent analyser was set at a mouth flow rate of
50mls/s and a pressure of 10cm H2O in line with current guidance from The European
Respiratory Society /American Thoracic Society recommendations for standardisation
of measurements (ATS/ERS, 2005). Two measurements were obtained at each time
point and the mean recorded. The machine was calibrated every 14 days and serviced
after 18 months as per the manufacturer's guidelines. A further single measurement was
taken for comparison with the smaller Niox® Mino device which has identical mouth
flow rate and pressure settings.
In addition, the Niox® Flex FlexFlow software was used to measure FENO at two
further flow rates of 30mls/s and lOOmls/s. These data were used to calculate an
estimate of alveolar exhaled nitric oxide and conducting airway exhaled nitric oxide
using the two compartment model ofNO airway dynamics (Pietropaoli et al., 1999).
Statistical Analysis
The data were analysed using the Minitab 16 Software (Minitab Inc, USA) unless
otherwise stated. Normality of distribution was checked using the Anderson-Darling
test with a p-value <0.05 considered significant for a not normal distribution. Data that
were not normally distributed were logio transformed prior to further analysis. Pre¬
operative patient characteristics, type of operation, histopathology and complications
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were compared between groups using the two proportion t-test or where numbers were
small Fisher's Exact t-test. Post-operative changes were compared using the Paired t-
test. Groups of patients were compared using the two-sample t-test. A p value <0.05
was considered significant. A repeated measures ANOVA model was created to
incorporate variance attributable to time points, type of surgery and pneumonia versus
no pneumonia. To determine relative risk for pneumonia, Youden's test (18) was
applied to parameters which were significantly higher in patients going on to develop
pneumonia. Having established the optimal cut-off for predicting pneumonia, the
relative risk for each parameter was determined using Fisher's test. Statistical
significance was considered to be at the p<0.05 level. The statistical program GraphPad
Prism 5 (GraphPad Software Inc. USA) was used for this purpose. A change in innate
immune parameters of 10% was considered to be clinically significant. 40 patients were
required to have a 90% power to detect a difference with a significance level of 0.01.
List of Reagents/Key Products
Alexa Fluor® 647 conjugated mouse IgG2b anti-Human CD 192 (CCR2) (BD, UK)
BD Cytometric Bead Array (CBA) Human Inflammatory Cytokines Kit II
BD FACS Lysing Solution lOx concentrate (BD, UK)
Bovine Serum Albumin (BSA) (Sigma, UK)
Bradford Reagent (Sigma, UK)
Buffer containing Phosphate Buffered Saline (PBS), pH 7.2, 0.5% bovine serum
albumin (BSA)
Calcium Chloride
CD 14 Human Microbeads (Miltenyi Biotec, Germany)
Escherichia coli (K-12 strain) Bioparticles®, Alexa Fluor® 488 conjugate (Invitrogen,
UK)
FITC conjugated rat IgG2b kanti-Human CX3CRI (MBL, International Corporation,
Mass., USA)
Iscove's Modified Dulbecco's Medium (IMDM) (Invitrogen, UK)
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Lipopolysaccharide (LPS) from Escherichia coli 0127:B8 (Sigma-Aldrich, USA)
MiniMACS™ Separator (Miltenyi Biotec, Germany)
Mouse Serum (Biosera, UK)
MS Columns (Miltenyi Biotec, Germany)
Nucleocounter® NC-100™ Reagent A and Reagent B (Chemometec A/S, Denmark)
Niox® Flex, Aerocrine AB; Smidesvagen, Sweden
Niox® Mino Aerocrine AB; Smidesvagen, Sweden
Pecoll (GE Healthcare)
PE-Cy™7 conjugated mouse IgGl k anti-human CD 16 (BD, UK)
PerCP-Cy™5.5 conjugated mouse IgG2a k anti-human CD14 (BD, UK)
Phosphate Buffered Saline (PBS) without calcium and magnesium XI and xlO
concentrate (Sigma, UK)
Pierce® BCA Protein Assay Kit (Thermo Scientific®, UK)
Quantichrom™ Urea Assay Kit (BioAssay Systems Ca. USA)
Sodium Citrate
Trypan Blue 0.4% (Sigma, UK)
V450 conjugated mouse IgG2a anti-human HLA-DR (BD, UK)
Zymosan A (Saccharomyces cerevisiae) Bioparticles® Alexa Fluor® 594 conjugate
(Invitrogen, UK)
Zymosan A (Saccharomyces cerevisiae) (Sigma, UK)




Ill - RESULTS - Innate Immune Function Following Major Anatomic Lung
Resection for Clinically Suspected Lung Cancer
This chapter evaluates the post-operative innate immune response to major lung
resection for suspected lung cancer. As well as describing general trends, comparisons
were drawn between lung resection undertaken utilising VATS and conventional
thoracotomy with the hypothesis that VATS would induce less trauma and thus
disturbance in immune function.
Patient Background
A total of 40 patients were included in the study. Sixty-five percent (n=26) of lung
resections were performed utilising a VATS approach with the remainder undergoing
conventional postero-lateral thoracotomy (35%, n=14). The type of surgery performed
was determined on clinical grounds. Three out of the 14 thoracotomy patients (20%)
were potential VATS cases for whom VATS resection was found technically
inappropriate leading to early conversion to thoracotomy and conventional open
resection.
The key clinical characteristics of patients in the two surgical groups are detailed in
Table 3.1. There were notably more males in the thoracotomy group (78.6% cf. 46.2%
p=0.027). Mean blood loss was lower in VATS patients (geometric mean 299 SD 2.3 cf.
88 SD 2.2 p<0.0005) although there was no significant difference in the post-operative
reduction in blood haemoglobin levels (13.6g/l SD 11.5 for thoracotomy and 12.7g/l SD
9.4 for VATS p=0.785). Mean duration of surgery was shorter for thoracotomy patients
(182 minutes SD 36.7 cf. 211 SD 44.8 p=0.034) but length of post-operative stay was
longer (geometric mean 8.2 SD 1.9 cf. 5.2 SD 1.4 p=0.024). Although the Thoracoscore
was slightly higher for the thoracotomy patients, no statistically significant difference
between the two groups was identified (3.1% SD 2.5 for thoracotomy cf. 1.9% SD 1.0
for VATS p=0.103).
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The final histopathological diagnosis and TNM stage are shown in Tables 3.2 and 3.3
respectively. While the study targeted primary lung cancer, two patients had a different
post-operative diagnosis (one was metastatic colorectal carcinoma and the other benign
Wegener's granulomatosis). Not surprisingly, VATS surgery had more patients with
early stage IA disease compared to thoracotomy (7.7% cf. 46.2% p=0.002). The specific
operation performed for each patient is shown in Table 3.4. In general terms,
thoracotomy involved a few higher risk operations including sleeve resection, chest wall
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Post-operative complications are detailed in Table 3.5. Criteria for diagnosis of
pneumonia and ALI/ARDS were defined prospectively and are specified in the
methodology chapter (Chapter II, Clinical Definitions). Excessive pain was defined as
pain not controlled with the usual post-operative analgesia regimen (described in
Chapter II, Post-Operative Analgesia) and urinary tract infection as positive culture on a
MSSU. Overall, there were no in-patient deaths or ALI/ARDS in both surgical groups.
21/40 (52.5%) patients did not suffer a complication. The most common post-operative
complication was chest infection (35%) followed by prolonged air leak (17.5%). There
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Serum Cytokines: IL-6, IL-8, IL-10, TNF-a, IL-12 and IL-ip
Cytokines are small cell-signalling protein molecules which modulate immune
responses. In order to evaluate general inflammatory trends post-operatively, serum
cytokines were measured. Post-operative increases in serum IL-6, IL-8 and IL-10 were
found as detailed in Figures 3.1-3.3. For all patients IL-6, IL-8 and IL-10 followed
similar kinetics with a rapid increase at 6hrs, peaking at 24hrs before declining at 48hrs.
Interestingly IL-6 peaked at 6hrs in thoracotomy patients before falling. All changes
were significant compared with the pre-operative value (p<0.0005). VATS patients
induced lower levels of cytokine at each time point compared to thoracotomy. For IL-6
this was statistically significant at 6hrs using a two-sample t-test (geometric mean ratio
1.61 95% CI 1.06-2.46 p=0.028). ANOVA modelling confirmed a significant post¬
operative trend for lower levels of IL-6 (p=0.026), IL-8 (p=0.018) and IL-10 (p=0.047)
in VATS compared to thoracotomy patients.
There were no statistically significant post-operative changes for TNF-a, IL-12 or IL-ip
(Figure 3.4). The trend for lower cytokine levels in VATS patients remained which was
significant for TNF-a (ANOVA p=0.031).
A comparison was made between pre-operative patient serum cytokines and a mixed-
gender population of a similar age without active cancer. Table 3.6 confirms the groups
were well matched in terms of age, gender and smoking status. Table 3.7 reveals small
but statistically significant differences between the groups for IL-6 (geometric mean
ratio 1.78 95% CI 1.13-2.79 p=0.017), IL-12 (mean difference 1.39pg/ml 95% CI
0.075-2.705 p=0.039) and TNF-a (mean difference 1.70pg/ml 95% CI 0.252-3.143
p=0.023). No statistically significant differences were found for IL-8, IL-ip and IL-10.
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are shown. Error bars represent the interquartile range. The data was log10 transformed prior to
undertaking paired T-tests. There was an overall significant increase in IL-6 from pre-operative
value at all time points (p<0.0005). VATS also induced a lower change in IL-6 levels compared
with thoracotomy which was statistically significant at 6hrs post-operatively on a two sample t-
test (p=0.028) denoted by the * symbol. ANOVA modelling confirmed significant change post¬
operatively for all patients (p<0.0005) and lower levels of IL-6 for VATS compared to
thoracotomy patients (p=0.026). n=40 for all time points except n=38 at 48hrs.
o , , , , ,
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Figure 3.2 Post-Operative Trend in Serum IL-8. Individual trend lines are shown for
thoracotomy and VATS groups. The data was not normally distributed thus the median values
are shown. Error bars represent the interquartile range. The data was log10 transformed prior to
undertaking paired T-tests. There was a significant change from pre-operative value at all time
points (p<0.0005) with IL-8 peaking at 24hrs (p<0.0005). There was no statistically significant
difference between VATS and thoracotomy at any specific individual time point. ANOVA
modelling confirmed significant change post-operatively for all patients (p<0.0005) with VATS
surgery inducing lower levels of IL-8 compared to thoracotomy patients (p=0.018). n=40 for all
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Figure 3.3 Post-Operative Trend in Serum IL-10. Individual trend lines are shown for
thoracotomy and VATS groups. The mean values are shown with error bars representing the
standard error of the mean. Paired T-tests did not reveal a significant post-operative change at
any time point (p<0.05). However, ANOVA modelling revealed a significant increase in IL-10
post-operatively (p<0.0005) peaking at 24hrs. VATS surgery induced lower levels of IL-10
























Figure 3.4 Post-Operative Trends in TNF-a, IL-12 and IL-ip. Individual trend lines are shown
for thoracotomy and VATS groups. Mean values are shown with error bars representing the
standard error. No statistically significant post-operative change was found. No significant
difference between VATS and thoracotomy groups was found using two-sample t-tests although
ANOVA modelling identified lower levels of TNF-a in VATS patients compared with thoracotomy
(ANOVA p=0.031). n=40 for all time points except n=38 at 48hrs.
Characteristic Control Group Patients p-value
n=10 n=40
Male, n (%) 6 (60.0%) 23 (57.5%) 0.885
Mean Age, Years (SD) 69.1(5.7) 66.6(7.9) 0.272
Current Smoker, n (%) 3(30.0) 13(32.5) 0.878
Table 3.6 Comparison of the Demographics and Smoking Status of the healthy control
group and patients. The two proportion t-test was used to compare the groups and no
statistically significant difference was found.
Cytokine Control Population Pre-Operative Patient p-value
(pg/mi) (pg/mi)
IL-12 6.10(1.60) 7.49(2.39) 0.039
TNF-a 5.07(1.71) 6.77(2.79) 0.023
IL-10 3.60(1.01) 3.95(1.09) 0.363
IL-6* 3.30(2.31-3.54) 5.33(4.19-6.36) 0.001
IL-8* 8.80(7.19-10.26) 11.35(8.76-13.43) 0.061
IL-1 (3 2.78(1.34) 3.62(1.13) 0.093
Table 3.7 Healthy Control Population vs. Pre-operative Patient Serum Cytokines. IL-6 and
IL-8 data were not normally distributed and were log10 transformed prior to further analysis. A
two sample t-test was used to compare the groups. Mean values with standard deviation in
brackets are shown except for IL-6 and IL-8 where median values are shown together with
interquartile range in brackets (denoted by *). Serum levels of IL-6, IL-12 and TNF-a were found
to be slightly higher in lung resection patients pre-operatively than healthy controls of a similar
age (p<0.05). No significant difference was found for IL-1, IL-8 and IL-10. N=40 for patients and
n=10 for controls.
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Post-Operative Changes in Blood Leucocyte Count, Platelets and Albumin
In addition to serum cytokine responses as a measure of inflammation, routine peri¬
operative blood parameters were recorded and analysed. Lung surgery invoked major
changes in the leucocyte cell counts (Figure 3.5). There was a post-operative
leucocytosis which rapidly increased on day one post-operatively with a small further
increase up to day 3 post-operatively (geometric mean ratio 1.42 95% CI 1.32-1.54
p<0.0005). This was caused primarily by a neutrophilia (geometric mean ratio 1.83 95%
CI 1.66-2.01 p<0.0005) and monocytosis (geometric mean ratio 1.37 95% CI 1.22-1.54
p<0.0005). Interestingly, there was a reduction in the lymphocyte count for all patients
which remained depressed up to three days post-operatively (geometric mean ratio 1.75
95% CI 1.58-1.95 p<0.0005). No significant difference was found between VATS and
thoracotomy patients. These trends were confirmed on ANOVA modelling.
The platelet count and serum albumin fell post-operatively for all groups of patients
(Figures 3.6 and 3.7). Platelet count reached a trough at day 2 (geometric mean 1.14
95% CI 1.09-1.2 p<0.0005) before increasing on day 3. Serum albumin fell post¬
operatively to a trough on day 2 although no measurements beyond day 2 were
performed (mean difference 7g/l 95% CI 5.91-9.52 p<0.0005). ANOVA modelling
noted significantly higher overall levels of serum albumin in VATS patients compared




















Pre-Operative Day 1 Day 2 Day 3
Figure 3.5 Post-Operative Changes in Leucocytes. [A] Serial total leucocyte (broken line)
and neutrophil counts (continuous line) in whole blood. Due to not normal distribution, data are
presented as medians, error bars represent interquartile range. ANOVA modelling revealed a
significant post-operative leucocytosis (p<0.0005) and neutrophilia (p<0.0005). N=40 for pre¬
operative and day 1 samples, n=30 on day 2 and n=26 on day 3. [B] Serial lymphocyte
(continuous line) and monocyte (broken line) counts in whole blood. Data are presented as
medians, error bars represent interquartile range. ANOVA modelling revealed a significant
monocytosis (p<0.0005) and a relative lymphopenia post-operatively (p<0.0005). N=40 for pre¬
operative and D1 samples, n=30 on day 2 and n=26 on day 3. All data were obtained from the












Figure 3.6 Post-operative Trend in Platelet Count. The data points represent the median
platelet count at each time point. Error bars represent the interquartile range. The data was
log-io transformed due to not normal distribution of data as determined by the Anderson-Darling
test. Paired T-tests and ANOVA modelling revealed a significant post-operative reduction in
platelet count (p<0.0005). Two sample t-tests and ANOVA modelling found no difference in
post-operative change between VATS and thoracotomy (p>0.05). Note n=40 for pre-operative
and day 1 samples but n=30 on day 2 and n=26 on day 3 samples. The data were obtained
from the NHS Lothian Haematology Laboratory.
Figure 3.7 Post-Operative Trend in Serum Albumin. The data points represent the mean
serum albumin level of all patients. Error bars represent standard errors of the mean. Paired T-
tests and ANOVA modelling revealed a significant post-operative reduction in serum albumin
(p<0.0005). There was a significant difference found between VATS and thoracotomy on
ANOVA modelling (p=0.001). Note n=40 for pre-operative and n=34 for day 1 samples. n= 21
on day 2. The data were obtained from the NHS Biochemistry laboratory.
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Blood Neutrophil Phagocytosis
A neutrophilia is well described after any significant surgical trauma. The function of
neutrophils post-lung resection is however less well characterised. Neutrophils were
isolated from whole blood using dextran sedimentation and Percoll extraction. Figure
3.8 [A] shows the purity of granulocytes achieved which was confirmed on cytospin
with Giemsa staining to be >99% neutrophils. Phagocytosis was then assessed using
fluorescently labelled E. coli and Zymosan assays which were assessed on flow
cytometry as described in Figure 3.9. The plated zymosan phagocytosis assay was
assessed by light microscopy as described in Figure 3.10.
A summary of the trends in post-operative neutrophil phagocytosis is shown in Figure
3.11. Suspended neutrophil phagocytosis of Zymosan pre-conjugated with Alexa
Fluor® 594 was most variable post-operatively with a significant trend towards
reduction on ANOVA modelling (p=0.047). There was no significant change in E. coli
pre-conjugated with Alexa Fluor® 488 (p=0.318) or plated Zymosan phagocytosis
(p=0.080) on ANOVA modelling which remained generally high for all patients.
Paired T-tests did not identify a significant reduction in suspended fluorescently
labelled Zymosan phagocytosis post-operatively (p=0.098 at 24hrs and 48hrs) but did
reveal a significant reduction in plated neutrophil Zymosan phagocytosis at 24hrs
(p=0.018) and an increase in E. coli phagocytosis at 48hrs (p=0.028) compared to pre¬
operative values. No significant difference between VATS and thoracotomy patients
were found (p>0.05, data not shown). There were also no significant differences in pre¬
operative phagocytosis compared to a healthy control group (data not shown).
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Figure 3.8 Flow Cytometry Check of Blood Preparation Purity. Neutrophils were isolated
from whole blood using dextran sedimentation and Percoll extraction. Forward Scatter (FSC-H)
and Side Scatter (SSC-H) represent cell size and granularity respectively. The gates were set
on the established FSC-H and SSC-H positions of blood cells. [A] The granulocyte layer was
shown on a cytospin preparation to consist of >99% neutrophils. [B] The Mononuclear layer
consisted of predominately monocytes and lymphocytes seen on cytospins. [C] After CD14+
magnetic bead labelling and passage through a magnetic column, monocyte purity was
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Figure 3.9 Flow Cytometry Analysis of Suspended Neutrophil Phagocytosis (£. coli).
Isolated neutrophils were cultured with fluorescently labelled £ coli. After culture, typan blue
was added and the cells washed before flow cytometry analysis. Forward Scatter (FSC-H) and
Side Scatter (SSC-H) represent cell size and granularity respectively. B530_30-A is the channel
detecting Alexa-Fluoro 488 which was pre-conjugated with E.coli. [A] The neutrophils were
gated on according to typical FSC-H and SSC-A location. [B] A gate was placed for positive
phagocytosis based on the autofluorescence of the unstained sample. [C] The positive
phagocytosis gate was then applied to all the samples of the patient. Red=E. coli and no serum
(Control), Blue=E. coli + serum (Cold) (Control), Orange=£. Coli and serum (96.4% positive).
The above analysis was from a single representative patient. The same analysis was performed
for Zymosan using the YG 610/20 channel.
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Figure 3.10 Light Microscopy Analysis of Plated Zymosan Phagocytosis. Images
presented above. Neutrophils were separated from whole blood and cultured in individual wells
of a 24-well Costar® plate for 30 minutes to enable cell adherence. Zymosan was then added
for 30 minutes before washing and perfoming a Giemsa stain. [A] Plated neutrophils alone i.e.
no zymosan or serum. [B] Plated neutrophils with non-opsonised zymosan i.e. no serum added
(control). Note clumps of zymosan but few in the neutrophil cytoplasm. [C] Plated neutrophils
with opsonised zymosan i.e. serum added. Note zymosan particles in the neutrophil cytoplasm.
Cells with >2 zymosan particles were considered positive for phagocytosis. These images were
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Figure 3.11 Summary of Post-Operative Trends in Neutrophil Phagocytosis. [A] The data
was not normally distributed thus median values from each assay are shown with error bars
representing the interquartile ranges. ANOVA modelling revealed a significant reduction in
suspended Zymosan phagocytosis post-operatively (p=0.047) although no difference was found
for E. coli (p=0.318) or plated Zymosan phagocytosis (p=0.080). Paired t-tests revealed a
significant reduction in plated neutrophil Zymosan phagocytosis at 24 hrs (p=0.018) and an
increase in E. coli phagocytosis at 48 hrs post-operatively (p=0.028) (denoted by *). [B-D] Trend
lines for individual patients are shown below revealing E.coli and plated Zymosan phagocytosis
to be generally high with an occasional outlier but much greater variability in suspended
Zymosan phagocytosis. No significant differences between VATS and thoracotomy patients
were found (p>0.05, data not shown). There was also no significant difference in baseline
phagocytosis compared to a healthy control group n=10 (p>0.05, data not shown). n=37 for
suspended E.coli phagocytosis, n=38 for suspended zymosan phagocytosis and n=40 for plated
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Cytokine Responses after Monocyte Stimulation with LPS
Monocyte function was examined peri-operatively to determine whether a hyper- or
hypo-inflammatory response was induced by lung resection. Monocytes were isolated
from whole blood using dextran sedimentation, Percoll extraction and positively
selected from the mononuclear layer using CD14+ labelled magnetic beads and passage
through a magnetic column. Purity following this process was assessed by flow
cytometry as shown in Figure 3.8 [B&C]. Monocytes were then stimulated with LPS or
no LPS (un-stimulated control).
Table 3.8 compares the cytokine response for the control patients and the pre-operative
patient sample. In the un-stimulated control for both groups, low levels of cytokine
were produced with the notable exception of IL-8. LPS induced a pro-inflammatory
response from monocytes with increased levels of IL-8, IL-6, IL-1 (3, TNF-a and IL-10.
There was no change in IL-12 levels following LPS stimulation. There was no
statistically significant difference in cytokine response after LPS stimulation between
the pre-operative patient samples and healthy control patients.
Figure 3.12 compares the patient monocyte response to LPS across the four time points.
Monocytes produced relatively more IL-8, IL-6 and TNF-a post-operatively which
reached statistical significance at 48 hrs (IL-8 geometric mean ratio 1.43 95% CI 1.10 -
1.85 p=0.007, IL-6 geometric mean ratio 1.42 05% CI 1.04-1.94 p=0.028, TNF-a
geometric mean ratio 1.34 95% CI 1.02-1.74 p=0.034). There was also a significant
increase for IL-8 at 6hrs (geometric mean ratio 1.48 95% CI 1.18-1.85 p=0.001). IL-10
levels fell post-operatively reaching significance at 48hrs (geometric mean ratio 1.45
95% CI 1.01-1.91 p=0.010). There was no significant change for IL-12 or IL-ip.
ANOVA modelling revealed a significant post-operative change for TNF-a (p=0.028)
and IL-8 (p=0.034) alone.
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No statistically significant difference was found when comparing VATS versus
thoracotomy patients on ANOVA modelling. Nevertheless, lower levels of IL-10 were
produced by monocytes from VATS patients compared to thoracotomy at 6 hrs post¬
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Monocyte Subset Changes
The existence of different populations of human monocytes is well established (Ziegler-
Heitbrock et al., 2010). The classical monocytes (CD14++ CD16") form the majority of
circulating blood monocytes. However, a non-classical (CD14+CD16++) subset has also
been identified with higher cytokine production and antigen presentation together with
an intermediate subset (CD14++ CD16+). The three principal monocyte subsets were
identified using five-colour flow cytometry analysis. Figure 3.13 describes the flow
cytometry analysis. The test tube with all five antibodies was used to compare
monocyte subset changes between the time points for each patient. Figure 3.14
illustrates the typical post-operative monocyte subset changes as determined on flow
cytometry.
Table 3.9 summarises the relative change in the three monocyte subsets post-operatively
for all patients. There was a statistically significant relative reduction in non-classical
monocytes post-operatively. This reduction was maximal at 6hrs post-operatively
(geometric mean ratio 2.6 95% CI 1.65-4.09 p<0.0005) which increased at 24hrs
(geometric mean ratio 1.64 95% CI 1.17-2.3 p=0.005) before falling again at 48hrs
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post-operatively (geometric mean ratio 2.04 95% CI 1.42-2.92 p<0.0005). There was no
significant relative change for the other monocyte subsets. There was no significant
difference found for VATS compared with thoracotomy patients.
However, calculation of the absolute number of each monocyte subset, taking into
account the overall monocyte count, revealed a significant increase in intermediate and
classical monocytes which caused this relative reduction in non-classical monocytes
(Table 3.10).
Figure 3.13 Flow Cytometry analysis of monocyte subsets. Mononuclear cells were isolated
from whole blood using dextran sedimentation and Percoll extraction. Five fluorescently
conjugated antibodies were used to identify monocyte subsets (CD14, CD16, HLA-DR,
CX3CR1, CCR2). An unstained sample and five single stains were used to compensate the data
with a mixture sample containing all five antibodies used to identify monocyte subsets. The
figure below demonstrates the five-colour flow cytometry analysis from a representative patient
at one time point. [A] Monocytes were identified based on typical size and granularity (forward
scatter (FSC-H) and side scatter (SSC-H) respectively). [B] Cells positive for HLA-DR staining
were selected. [C] Three monocyte populations were identified based on CD14+ and CD16+
staining. [D&E] CCR2 and CX3CR1 staining confirmed correct identification of monocyte










Figure 3.14 Monocyte Subset Changes Following Lung Resection. Monocytes were
labelled and analysed as described in Figure 3.13. The relative post-operative changes in the
three monocyte subsets are illustrated in the flow cytometry quadrants above (obtained from a
single representative patient). The percentage of cells in each of the four quadrants was used to
calculate the relative change in subsets and, in turn, the absolute change proportionate to the
total monocyte count.
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BAL Cell Concentration, Total Protein and Cytokine Response After Lung
Resection
BAL was used as a means of assessing the early impact of surgical trauma on the non-
operated, comparatively healthy lung. A different lobe of the contra-lateral lung to the
culprit lesion was sampled pre-operatively and immediately post-operatively prior to
extubation. Table 3.6 details the lobes sampled from each patient and the volume of
lavage fluid returned to the suction trap. The median return was 43mls pre-operatively
(21.5%) and 45mls post-operatively (22.5%). No statistically significant difference was
found in return volume between the time points (p=0.243).
The mean concentration of cells (millions/ml) in the BAL fluid increased post¬
operatively (Figure 3.15). The geometric mean ratio between pre-operative and post¬
operative BAL was 0.57 (95% CI 0.28-0.37 p=0.012). Differential cell count revealed
an increase in neutrophils post-operatively however this was not statistically significant
(Table 3.12). The total protein (pg/ml) also increased post-operatively with a geometric
mean ratio of 0.61 (95% CI 0.40-0.95 p=0.029) (Figure 3.16). There was no significant
difference for VATS versus thoracotomy patients for cell concentration, differential cell
count and total protein using Paired T-tests and ANCOVA modelling.
Surgery induced an early cytokine response as detailed in Figure 3.17. There was a
post-operative increase in IL-6 (geometric mean ratio 0.40 95% CI 0.26-0.61
p<0.0005), IL-8 (geometric mean ratio 0.49 95% CI 0.28-0.87 p=0.017) and IL-10
(geometric mean ratio 0.80 95% CI 0.66-0.96 p=0.018). However, there was an
additional increase in IL-1(3 (geometric mean ratio 0.48 95% CI 0.30-0.75 p=0.002) in
the BAL which was not found in the serum 6hrs later. There was no significant change
in TNF-a or IL-12 (median value =0, data not shown). ANCOVA modelling or paired t-
tests did not reveal any difference for VATS versus thoracotomy patients.
Location of Lobe Lavaged Return Volume Lobe Lavaged Return Volume
Lesion Pre-Operative (mls)/200mls Post-Operative (mls)/200mls
LUL RLL 51 RML 55
LUL RLL 47 RML 25
RUL No scope No scope
RML LLL 45 LUL 65
LLL RLL 43 RML 55
LUL RLL 53 RML 35
LUL RLL 55 RML 18
LUL RLL 39 RML 19
RML LLL 52 Lingula 45
LUL RLL 45 RML 65
LUL RLL 97 RML 22
LUL RLL 40 RML 35
LUL RLL 38 RML 70
RLL LLL 55 Lingula 23
LUL RLL 100 RML 55
RLL LLL 45 Lingula 62
LUL RLL 55 RML 8
LLL&LUL RLL 60 RML 70
LUL RLL 44 RML 75
RUL LLL 41 Lingula 75
RUL LLL 25 Lingula 30
LUL RLL 15 RML 20
RML&RLL LLL 45 Lingula 62
L Hilum/LUL RLL 60 Nil - Pneumonectomy
RUL LLL 35 Lingula 27
RUL LLL 30 Lingula 9
RUL LLL 19 No scope
RUL LLL 42 Lingula 52
RUL LLL 32 Lingula 50
RLL LLL 32 Lingula 50
RUL LLL 38 Lingula 20
LUL RLL 74 RML 40
RUL LLL 24 Nil - Pneumonectomy
RML LLL 30 Lingula 40
LUL RLL 33 RML 45
RUL LLL 54 Lingula 40
RML LLL 38 Lingula 44
LUL RLL 38 RML 60
RUL LLL 58 Lingula 54
RML&RLL LLL 42 Lingula 55




Table 3.11 Summary of BAL Sampling Location and Volume Returned. BAL was
undertaken after intubation for bronchoscopy and mediastinoscopy (pre-operative) and after
lung resection prior to extubation (post-operative). A different lobe of the contra-lateral lung to
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the culprit lesion was sampled on each occasion. A total of 200mls of 0.9% NaCI (in four 50ml
aliquots) was injected and the total volume returned shown. The data was not normally
distributed as determined by the Anderson-Darling test. A median value and interquartile range
is shown for each time point. A Paired t-test was undertaken after log10 transformation revealing








Figure 3.15 Increase in BAL Cell Concentration After Lung Resection. BAL was performed
pre-operatively and post-operatively. On both occasions the non-operated lung was lavaged,
and a different segment was sampled in the pre- and post-operative procedures. The data were
not normally distributed and thus presented as median values with error bars representing the
interquartile range. A paired T-test was performed after log10 transformation. Geometric mean
pre-operatively was 0.09 which increased to 0.16 post-operatively (p=0.012). No significant
difference between VATS and thoracotomy patients was found using paired t-tests and
ANCOVA modelling (p>0.05, data not shown). n=36.
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Cell Type Pre-Operative Post-Operative p-value
Median (IQR) Median (IQR)
Macrophages/Monocytes 93 (75-96) 84 (45-92) 0.232
Neutrophils 4(2-23.5) 13(3-49) 0.176
Lymphocytes 2(1-3) 3(1-4) 0.259
Other <1%(0) <1 % (0) 1.000
Table 3.12 Changes in BAL Differential Cell Count Following Lung Resection. A different
lobe of the contra-lateral lung to the culprit lesion was sampled on each occasion. A cytospin
was performed of the pellet of cells obtained after centrifugation. Differential cell count was
undertaken after Giemsa staining. The relative change in cell type counts were compared
between the two time points. The data were not normally distributed, as determined by the
Anderson-Darling test. Median and interquartile ranges are shown. Log10 transformation was














Figure 3.16 Increase in BAL Total Protein Following Lung Resection. BAL was undertaken
prior to surgical staging from the contralateral lung to the culprit lesion and from another lobe of
the contra-lateral lung after completion of lung resection. Pierce assay was used to assess total
protein levels in BAL supernatant and was reported in pg/ml. The data were not normally
distributed. Median values and interquartile ranges are shown. After log10 transformation a
paired t-test was performed. Geometric mean pre-operatively was 97.07 which increased to
158.12 (p=0.029). No significant difference between VATS and thoracotomy patients was found
































Figure 3.17 Post-Operative Increase in BAL Cytokines. BAL was undertaken prior to surgical
staging from the contralateral lung to the culprit lesion and from another lobe of the contralateral
lung immediately after completion of lung resection. [A&B] Cytokines in BAL supernatant were
measured and required log10 transformation due to not normal distribution prior to undertaking a
paired T-test. The median values at each time point and p-values are shown in the chart. Error
bars represent the interquartile range. There was no significant difference in IL-12 or TNF-a
(median value at each time point =0, data not shown). ANCOVA modelling did not reveal a
difference between VATS and thoracotomy. [C-F] The individual patient post-operative trends











































In an effort to identify a non-invasive measure of airway inflammation after lung
resection, exhaled nitric oxide was evaluated. FENO (Fractional exhaled nitric oxide)
had previously been shown to be a useful measure of airway inflammation in asthmatic
patients. In this study, FENO was measured using the gold standard chemiluminescence
analyser (Niox Flex) and the smaller electrochemical sensor (Niox Mino) at each time
point. Both were set at flow rate 50mls/sec. Figure 3.18 demonstrates a strong positive
correlation between the two methods (r=0.902, p<0.0005). In addition, the Altman-
Bland plot suggested a high degree of agreement between the devices (Figure 3.19).
Figure 3.20 depicts the post-operative trend in exhaled nitric oxide. Importantly, not all
patients could perform all of the post-operative measurements thus the paired t-test
resulted in slightly different pre-operative mean values for each post-operative time
point. There was an overall tendency towards reduction in exhaled nitric oxide post¬
operatively which reached statistical significance at 48hrs (geometric mean ratio 1.2
95% CI 1.02-1.46 p=0.029). There was no significant difference found between patients
undergoing resection via VATS or thoracotomy (p>0.05, data not shown).
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Figure 3.18 Comparison of Exhaled Nitric Oxide (FENO) Measurements from Niox Flex
and Niox Mino Devices. FENO readings in parts per billion (ppb) were not normally distributed
thus log10 transformed for the scatter plot. Pearson correlation coefficient confirmed a strong
positive association r=0.902 (p<0.0005).
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Figure 3.19 Altman-Bland plot of Niox Mino versus Niox Flex. The above figure suggests a











Figure 3.20 Post-Operative Change in Exhaled Nitric Oxide (FENO). The data were not
normally distributed thus median exhaled nitric oxide measurements from the Niox Flex are
shown. Error bars represent the interquartile range. The pre-operative sample was compared to
the three post-operative time points using a paired t-test. Due to some patients not being able to
complete all three post-operative measurements, the pairing to post-operative results led to
slightly different pre-operative median values for each paired t-test (pre-operative n=40, 6hrs
post-operative n=31, 24 and 48 hrs post-operative n=32). There was a general trend towards
reduction in exhaled nitric oxide which reached significance at 48 hrs (geometric mean ratio 1.2
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Variable flow rates (30mls/hr, 50mls/hr and lOOmls/hr) enabled the alveolar nitric oxide
to be calculated at each time point using the two-compartment model of airway
dynamics. However, there was no significant change found (Figure 3.21). ANOVA
modelling did not reveal a significant post-operative change in FENO or alveolar nitric
oxide or difference between surgical approaches.
Pre-operative FENO measurements and alveolar nitric oxide calculations from patients
were compared with the control group of a similar age (Table 3.13). No statistically
significant differences were found although there was a notably higher median value of
FENO in the control group which fell short of significance (geometric mean ratio 1.49
















Figure 3.21 Post-Operative Change in Derived Alveolar Nitric Oxide (FENO). The data
were not normally distributed thus median values for alveolar nitric oxide are shown. Error bars
represent the interquartile ranges. The measurements were derived using the two-compartment
model of airway dynamics and variable flow rates of 30ml/second, 50mls/second and
100mls/second. The pre-operative sample was compared to the three post-operative time
points using a Paired t-test after log™ transformation. Due to some patients not being able to
complete all three post-operative measurements at three flow rates, the pairing to post¬
operative results led to slightly different pre-operative median values for each paired t-test (pre¬
operative n=39, 6hrs post-operative n=29, 24hrs n=27 and 48 hrs post-operative n=30). No
statistically significant difference was found post-operatively at any time point and ANOVA
modelling found no significant post-operative change for alveolar nitric oxide.
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Pre-Operative Patient Control Patient p-value
Median and (IQR) (ppb) Median and (IQR) (ppb)
FENO 14.1 (8.8-18.3) 23.3(21.0-30.7) 0.055
Derived Alveolar NO 4.9 (3.5-6.5) 5.6 (3.9-7.7) 0.913
Table 3.13 Comparison of Patient and Control Group Exhaled Nitric Oxide. The data were
not normally distributed thus median and interquartile (IQR) ranges are shown. The data was
log-io transformed prior to using a two-sample t-test. No statistically significant differences were
found (p<0.05). Measurements from the Niox Flex are shown. n=40 for patient FENO, n=39 for
patient derived alveolar NO and n=10 for controls.
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IV - RESULTS -Biomarkers of Post-Operative Pneumonia Following Major
Anatomic Lung Cancer Resection for Clinically Suspected Lung Cancer
The principal purpose of the study was to examine innate immune parameters peri-
operatively in patients undergoing lung cancer resection to identify any significant
differences between those patients whom subsequently developed post-operative
pneumonia and those whom did not with a view to identifying early biomarkers. The
primary hypothesis proposed that patients have either heightened or suppressed immune
function pre-operatively or early in the post-operative course which could predispose
them to a hospital acquired pneumonia.
Prospective criteria for diagnosis of post-operative pneumonia were defined. The
essential component was consolidation on the 72-hour post-operative chest roentogram,
blindly reported by a Consultant Radiologist, plus at least two of WBC count >11.0 or
<4.0x109/l, temperature >38.0°C or <35.5°C or positive microbiology culture from
sputum. Patients were divided into pneumonia or no pneumonia groups and innate
immune parameters compared. Significantly different parameters were subsequently
evaluated for their individual predictive strength for post-operative pneumonia.
Patient Background
Forty patients enrolled in the study underwent lung cancer resection. Fourteen patients
(35%) met the prospectively defined criteria for post-operative pneumonia. No patient
fulfilled the prospectively defined diagnostic criteria for ALI/ARDS (Chapter II,
Clinical Definitions).
Table 4.1 compares the clinical characteristics of the two groups. There were no
statistically significant differences found except for TCO(60.9% predicted cf. 77.9%
predicted p=0.010). Other measures of lung function were lower in pneumonia patients
but these were not significantly different to other patients. Tables 4.2 and 4.3 summarise
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the final histopathology and the TNM lung cancer stage respectively of the groups.
There were no statistically significant differences found. Although the study targeted
lung cancer patients, two patients in the no pneumonia group were discovered to have a
diagnosis other than lung cancer post-operatively (metastatic colorectal carcinoma and
Wegener's granulomatosis).
The specific operations performed in each group are detailed in Table 4.4. It is
important to note that approximately two-thirds of all cases were undertaken using
VATS surgery explaining why approximately two-thirds of pneumonia cases were
VATS cases. No statistically significant difference in terms of operation performed was
found between the two groups.
Table 4.5 compares the two groups in terms of other post-operative complications.
There were no significant differences between the groups for individual complications
although pneumonia patients were more likely to suffer another major complication
including respiratory failure, retention of secretions requiring mini-tracheostomy and/or
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LungCancerTNMStage
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Complication



























































































Table4.5ComparisonfOtherPost-OperativeplicationsBe w eneumoniandNP t en s.-valuref rto pneumoniav rsuspngroupandwerecalculat dusi gthFish 'exactt.Ntatis icallyig ificantdiffer n s found.
Serum Cytokines: IL-8, TNF-a, IL-12, IL-10, IL-lp and IL-6
Six serum cytokines were compared between pneumonia and no pneumonia patients.
There were no statistically significant differences found between the groups pre-
operatively but post-operatively significant differences emerged for IL-8 and TNF-a.
Figure 4.1 shows the group trends for IL-8. Pneumonia patients had higher levels of IL-
8 at each time point which peaked at 24hrs. The difference in post-operative change
between the groups was statistically significant at 48hrs (geometric mean ratio 1.43
95% CI 1.04-1.97 p=0.031). ANOVA modelling found no overall significant difference
for IL-8 between pneumonia and no pneumonia groups (p=0.109).
Figure 4.2 demonstrates the post-operative change in TNF-a for pneumonia compared
with no pneumonia patients. It is important to note that there was no significant change
in TNF-a post-operatively for all patients (please refer to serum cytokines in chapter
III). However, a divergence in responses was found between the groups with an initial
fall in TNF-a for pneumonia patients and an increase in no pneumonia patients at 6hrs
post-operatively. The small difference between the groups reached statistical
significance at 24hrs (mean difference 2.259pg/ml p=0.023). By 48hrs both groups had
increased TNF-a levels. ANOVA modelling however found no statistically significant
difference post-operatively between the groups (p=0.729). No statistically significant
differences were found for the other measured cytokines. The post-operative trends
between the two groups are shown in Figure 4.3.
Time (Hrs)
Figure 4.1 Post-Operative Change in Serum IL-8 for Pneumonia Compared with No
Pneumonia Patients. The data were not normally distributed thus median values of IL-8 are
shown. Error bars represent the interquartile range. The post-operative change was calculated
and log10 transformed. Pneumonia versus no pneumonia groups were compared using a two
sample t-test. Pneumonia patients had a larger change in IL-8 post-operatively which was
significant at 48hrs (highlighted by the * symbol, geometric mean ratio 1.43 p=0.031). However,
ANOVA modelling did not reveal an overall difference in IL-8 for pneumonia versus no
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Figure 4.2 Post-Operative Change in Serum TNF-a for Pneumonia Compared with No
Pneumonia Patients. The data were not normally distributed thus median values of TNF-a
were calculated. Error bars represent the interquartile range. The post-operative change was
calculated and log10 transformed. Pneumonia versus non-pneumonia groups were compared
using a two sample t-test. Although there was no significant overall post-operative change,
there was a statistically significant difference between the groups at 24hrs (highlighted by the *
symbol, mean difference 2.259pg/ml p=0.023). However, ANOVA modelling did not reveal an
overall difference in TNF-a for pneumonia versus no pneumonia patients (p value on chart).
N=40 at each time point except 48hrs post-operatively where n=38.
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Figure 4.3 Post-Operative Changes in Serum IL-12, IL-10, IL-ip and IL-6 for Pneumonia
versus No Pneumonia Patients. [Panels A-D] The data were not normally distributed thus
median values are shown below. Error bars represent the interquartile range. The post¬
operative change was calculated and log10 transformed. Pneumonia versus non-pneumonia
groups were compared using a two-sample t-test. No statistically significant difference was
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Leucocyte, Neutrophil, Monocyte, Platelet and Serum Albumin Counts
Routine NHS haematology and biochemistry counts were analysed to determine if any
early changes emerged for pneumonia compared with no pneumonia patients. Figure
4.4 compares the pre-operative leucocyte and neutrophil count between the groups.
Patients subsequently developing pneumonia had higher pre-operative leucocyte counts
(geometric mean ratio 1.26 95% CI 1.07-1.49 p=0.007) and higher neutrophil counts
(geometric mean ratio 1.31 95% CI 1.06-1.63 p=0.015) compared with no pneumonia
patients. The values however were within the normal NHS reporting range. There was
no statistically significant difference in pre-operative monocyte or lymphocyte count
between the groups.
The post-operative trend in leucocyte count between the groups is profiled in Figure
4.5. ANOVA modelling revealed a significant overall post-operative difference between
pneumonia and no pneumonia groups (p=0.017) despite individual time point t-tests
showing no significant difference between the groups.
The post-operative trend in neutrophil count mirrored the leucocyte count (Figure 4.6).
ANOVA modelling revealed an overall significant difference between pneumonia and
non-pneumonia patients (p=0.024). Two sample t-tests for individual time points
revealed no difference between the groups.
There was no significant difference for change in monocyte count between pneumonia
and no pneumonia patients (data not shown). However, ANOVA modelling identified a
complex interaction between time, pneumonia or not and VATS versus open surgery
(p=0.005). The numbers were too small however for meaningful comparisons to be
drawn.
Figure 4.7 summarises the post-operative trend in serum albumin between the two
groups. ANOVA modelling identified significantly lower levels of serum albumin in
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pneumonia patients compared with no pneumonia patients (p=0.020) although there was
no significant difference found at any specific time point. A complex interaction was
identified between time point, type of surgery and pneumonia or not although the
numbers were too small to allow meaningful sub-group analysis. No significant
difference was identified between the groups for baseline platelet count or post¬











Figure 4.4 Pre-Operative Leucocyte and Neutrophil Counts in Patients Subsequently
Developing a Post-Operative Pneumonia. The data were not normally distributed thus
median values are shown. Error bars represent the interquartile ranges. The data was log10
transformed prior to performing a two sample t-test. Patients whom developed post-operative
pneumonia had a relatively high leucocyte count pre-operatively (geometric mean ratio 1.26
p=0.007). This was due to a relatively high pre-operative neutrophil count (geometric mean ratio
1.3 p=0.015). The data were derived from NHS Lothian Haematology Laboratory. n=40.
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Pre-Operatiue Day 1 Day 2 Day 3
Figure 4.5 Post-Operative Trend in Leucocyte Count Differs Between Pneumonia and No
Pneumonia Patients. The data were not normally distributed thus the median value at each
time point is shown. Error bars represent the interquartile range. Post-operative change was
calculated and log10 transformed prior to further analysis. A two-sample t-test did not reveal any
statistically significant differences between the groups. However, ANOVA modelling revealed an
overall significant difference between pneumonia and non-pneumonia patients (p value on
chart). Data were derived from NHS Lothian Haematology Laboratory. n=40 pre-operatively and












P re-Operative Day 1 Day 2 Day 3
Figure 4.6 Post-Operative Trend in Neutrophil Count Differs Between Pneumonia and No
Pneumonia Patients. The data were not normally distributed thus the median value at each
time point is shown. Error bars represent the interquartile range. Post-operative change was
calculated and log10 transformation prior to further analysis. A two-sample t-test did not reveal
any statistically significant differences between the groups. However, ANOVA modelling
revealed an overall significant difference between pneumonia and non-pneumonia patients (p
value on chart). Data were derived from NHS Lothian Haematology Laboratory n=40 pre-
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Figure 4.7 Pneumonia Patients Have Lower Early Post-Operative Albumin Counts. The
median value at each time point is shown as the data was not normally distributed. Error bars
represent the interquartile range. Post-operative change was calculated and the data log10
transformed prior to further analysis. A two-sample t-test did not reveal any statistically
significant differences between the groups. ANOVA modelling however showed a significant
overall difference between pneumonia and no pneumonia (p value on chart) and type of surgery
(p=0.001). n=40 pre-operatively, n=35 D1 and n=21 D2.
Neutrophil Phagocytosis
The data above identified higher leucocyte and neutrophil counts pre-operatively in
pneumonia patients compared with no pneumonia patients with an overall higher post¬
operative trend on ANOVA modelling. The functional capacity of neutrophils was also
assessed peri-operatively using three assays of phagocytosis. Figure 4.8 summarises the
trends of pneumonia and no pneumonia groups. No significant differences were found
pre-operatively or post-operatively.
Figure 4.8 Summary of Post-Operative Trends in Neutrophil Phagocytosis for Pneumonia
and No Pneumonia Patients. [Panels A-C] The data were not normally distributed thus the
median phagocytosis percentage is shown. Error bars represent the interquartile range. The
data was log10 transformed and the groups compared with a two sample t-test which revealed
no significant difference at any time point between the groups. ANOVA modelling confirmed no
overall significant difference between pneumonia and no pneumonia groups (p values on
charts). n=37 for suspended E.coli phagocytosis, n=38 for suspended zymosan phagocytosis
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BAL
BAL was performed pre-operatively at the time of the staging bronchoscopy prior to
mediastinoscopy and immediately after lung resection. Each lavage was undertaken
from a different lobe of the contralateral lung to the culprit lesion. This provided a
unique insight into the early inflammatory response to surgery in the non-operated lung
and any early differences to be identified between those patients subsequently
developing post-operative pneumonia and those not.
The overall concentration of cells in BAL sampled pre-operatively was found to be
higher in patients subsequently developing post-operative pneumonia (geometric mean
ratio between the groups was 2.07 95% CI 1.19-3.6 p=0.012, Figure 4.9). No significant
difference was found between the groups for the change in BAL cellular concentration
post-operatively. The median neutrophil count was slightly higher in pneumonia
patients post-operatively although this was not statistically significant (Table 4.6).
BAL cytokines (IL-ip, IL-6, IL-8, IL-10, IL-12 and TNF-a) were compared between
the two groups at baseline and post-operatively. No statistically significant differences
were found (ANCOVA p-values were IL-12 p=0.472, TNF-a p=0.488, IL-10 p=0.200,
IL-6 p=0.251, IL-ip p=0.760 and IL-8 p=0.780). Figure 4.10 details the trends for each















Figure 4.9 Pre-Operative BAL Cellular Concentration was Higher in Patients
Subsequently Developing Post-Operative Pneumonia. A different lobe of the contra-lateral
lung to the culprit lesion was sampled on each occasion. The data was not normally distributed
thus the median pre-operative BAL cellular concentration is shown together with interquartile
ranges. The data was log10 transformed and the two groups compared using a two sample t-
test. Post-operative pneumonia patients had a higher pre-operative BAL cellular concentration
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Figure 4.10 Post-Operative Change in BAL Cytokines for Post-Operative Pneumonia and
No Pneumonia Patients. BAL was undertaken prior to surgical staging from the contralateral
lung to the culprit lesion and from another lobe of the contralateral lung immediately after
completion of lung resection. Cytokines in the supernatant were measured. [Panels A-D] The
data for IL-6, IL-8, IL-1(3 and IL-10 were not normally distributed and are thus reported as
medians with the error bars representing the interquartile ranges. The data for IL-12 and TNF-a
were generally below the limits of detection and are not shown. Post-operative change was
calculated and the two groups compared using a two-sample t-test after log10 transformation.
No statistically significant differences were found between the groups. ANCOVA modelling also
did not reveal a significant difference between pneumonia and no pneumonia groups (p value





















































Monocyte Subsets and Ex-vivo Monocyte Cytokine Response to LPS
Chapter III revealed that there was a relative decrease in the CD 14" CD16++ monocytes
due to an expansion in the absolute numbers of CD14++CD16" and CD14++CD16+
subsets. This pattern was found in both pneumonia and no pneumonia patients with no
statistically significant differences between the groups found (data not shown).
Six cytokines were measured in the supernatant of isolated monocytes stimulated with
LPS. IL-12 levels were found to be significantly lower pre-operatively in patients whom
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subsequently developed a post-operative pneumonia compared to no pneumonia
(geometric mean ratio 1.19 95% CI 1.00-1.27 p=0.008, Figure 4.11). There was no
other pre-operative difference between the groups for the other measured cytokines (IL-
1P, IL-6, IL-8, IL-10 and TNF-a).
Figure 4.12 details the post-operative changes between the groups. Significant
differences were found in IL-10, IL-6 and IL-8 responses for pneumonia compared with
no pneumonia patients. Levels of IL-6 and IL-8 were higher at all time points in patients
with pneumonia. Median levels of IL-6 increased sharply at 6hrs then continued to
increase reaching statistical significance at 24hrs (geometric mean ratio 1.50 95% CI
1.02-2.19 p=0.040) and 48hrs (geometric mean ratio 1.20 95% CI 1.02-2.19 p=0.014).
This contrasted with no pneumonia patients whose IL-6 levels peaked at 6hrs post¬
operatively before falling.
Levels of IL-8 increased sharply at 6hrs in pneumonia patients and then rose only
slightly higher at 24hrs and 48hrs. Although levels in the no pneumonia group were
lower at all time points, there was a median increase at 48hrs. Despite this, the
difference between the groups was significant at 48hrs (geometric mean ratio 1.20 95%
CI 1.06-1.34 p=0.004). The profile for IL-10 in pneumonia patients was marginally
lower than no pneumonia patients until after 6hrs where a steady increase in pneumonia
patients and fall in no pneumonia patients led to a significant difference at 24hrs
(geometric mean ratio 1.24 95% CI 1.05-1.47 p=0.014). No significant difference was
found between the groups for IL12-, IL-ip or TNF-a response. ANOVA modelling did













Figure 4.11 Pre-Operative IL-12 was Lower in Patients Subsequently Developing Post-
Operative Pneumonia. Monocytes were isolated from whole blood using dextran
sedimentation, Percoll extraction and positively selected from the mononuclear layer using
CD14+ magnetically labelled beads. Cells were stimulated with 100ng LPS for 18hrs and the
supernatant frozen at "80°C until later cytokine analysis. The average of two wells of monocytes
stimulated with LPS was calculated and the data adjusted for total protein in each well. IL-12
levels were found to be significantly lower pre-operatively in patients whom developed a post¬
operative pneumonia compared to no pneumonia (geometric mean ratio 1.19 p=0.008). n=40.
Figure 4.12 Increased Post-Operative IL-6, IL-8 and IL-10 in The Supernatant of
Monocytes Stimulated with LPS. Monocytes were isolated from whole blood using dextran
sedimentation, Percoll extraction and positively selected from the mononuclear layer using
CD14+ magnetically labelled beads. Cells were stimulated with LPS for 18hrs and the
supernatant analysed for cytokines. [Panels A-F below] The data was not normally distributed
thus the median value is shown. Error bars represent the interquartile ranges. Post-operative
change was calculated and the data log10 transformed. There was a general trend for higher
cytokine levels in pneumonia patients with statistically significant differences at specific time
points shown by the p-value on the charts. There were no statistically significant differences at
any time point for IL-12, IL-1(3 and TNF-a. ANOVA modelling did not reveal any significant
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Exhaled nitric oxide was evaluated as a non-invasive measure of airway inflammation
after lung resection which could potentially identify patients at risk of pneumonic lung
processes early. The general post-operative trend for initial reduction in exhaled nitric
oxide was found for both pneumonia and no pneumonia groups with no statistically
significant difference found at any time point (Figure 4.13). Pneumonia patients did
however show a sharper initial reduction in exhaled nitric oxide before a median
increase in FENO at 48 hours. Using the two-compartment model of airway dynamics
and measuring exhaled nitric oxide at three flow rates, alveolar nitric oxide was
estimated (Figure 4.14). The trend broadly followed FENO except the no pneumonia
patients had a small increase in alveolar NO at 6 hours compared to a decrease for
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Figure 4.13 Comparison of Exhaled Nitric Oxide (FENO) in Pneumonia and No
Pneumonia Patients. The data were not normally distributed thus median values from the Niox
Flex are shown. Error bars represent the interquartile ranges. Post-operative change was
calculated and the groups compared using the two-sample t-test. No statistically significant
differences were found. ANOVA modelling also found not difference between the groups (p
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Figure 4.14 Comparison of Alveolar Nitric Oxide in Pneumonia and No Pneumonia
Patients. The data were not normally distributed thus median derived values are shown with
error bars representing the interquartile range. They were calculated using the two-
compartment model of airway dynamics and variable flow rates of 30ml/second, 50mls/second
and 100mls/second. Post-operative change was calculated and the two groups compared after
log10 transformation using the two-sample t-test and ANOVA modelling. No statistically
significant differences were found. ANOVA p value is shown on the chart. N=39 pre-operatively,
n=29 6hrs post-operatively, n=27 24hrs post-operatively and n=30 48 hrs post-operatively.
Biomarkers Associated with Post-Operative Pneumonia
The above analysis identified a number of innate immune markers that were statistically
significant between patients developing post-operative pneumonia and those not. These
are summarised in Table 4.7. The capacity of these individual biomarkers to distinguish
pneumonia patients from no pneumonia patients was tested. Three pre-operative and
two post-operative parameters appealed to retain significance in predicting pneumonia.
Pre-operatively, a blood neutrophil count above 5.04x109/L had a relative risk (RR) for
pneumonia of 3.3 (95% confidence interval (CI95) 1.1-10.1), and a BAL cell count of
greater than 1.04xl05/ml had a RR of 3.4 (CI95 1.3-9.0), whilst LPS-stimulated
monocyte secretion of IL-12 of less than 0.15 pg/ml/pg protein had a RR of 3.0 (CI95
1.2-7.3). At 24 hours post-operatively, LPS-stimulated release from monocytes of IL-10
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greater than 1.99 pg/ml/pg protein (RR 4.1, CI95 1.3-12.3) and IL-6 greater than 414
pg/ml/pg protein (RR 3.1, CI95 1.2-8.1) were predictive of pneumonia.
123







































Table4.7Biomarkersssociatedwiththdevelopm ntfpost-operativeneumonia.Dpr sensd nitIQRs brackets.St tisticalanalysiswat osample-testN=40forlcomp risonsexceptpre-op at veBAL,rumndmo o yt supernatantex imentsa48hr ,w eren=38.Allmonocytesup rvalu sref rt ocyttim l dxivoth lipopolysaccharide.
V - DISCUSSION
This study has demonstrated that there are early and profound changes in innate
immune function following major lung resection, many of which are reduced following
VATS lobectomy compared with lung resection undertaken via conventional
thoracotomy. Specifically, VATS surgery induced a smaller increase in serum
cytokines, and was associated with higher serum albumin counts together with reduced
IL-10 release from LPS-stimulated monocytes at 6hrs post-operatively compared with
thoracotomy. Further, the magnitude of the innate immune response appears associated
with the risk of post-operative pneumonia. A relative leucocytosis in blood or BALF
pre-operatively and heightened responsiveness of blood monocytes to LPS early in the
course of surgery, seemed particularly associated with later development of pneumonia.
Together, these findings suggest that innate immune function may influence the
pathogenesis of post-operative pulmonary inflammation and could potentially aid
stratification of post-operative risk in the future enabling targeted prophylactic or
therapeutic strategies.
Post-Operative Systemic Inflammatory Reponses - VATS versus Thoracotomy
VATS lobectomy was associated with lower release of post-operative serum cytokines;
pro-inflammatory IL-6 and IL-8 together with anti-inflammatory IL-10 levels were all
significantly lower (Figures 3.1-3.3). Although there was no significant post-operative
change in TNF-a, higher levels were associated with thoracotomy patients (Figure 3.4).
There was no post-operative change or difference found between the groups for IL-ip
or IL-12 (Figure 3.4). These findings are consistent with earlier published studies. Yim
et al. identified reduced secretion of IL-6, IL-8 and IL-10 following VATS lobectomy
in patients with stage INSCLC compared with thoracotomy (Yim et al., 2000). No
post-operative change or difference was found for IL-ip and TNF-a. Craig et al. also
identified lower IL-6 and CRP release following VATS lobectomy compared with
thoracotomy (Craig et al., 2001). Nagahiro et al. found reduced IL-6 secretion after
VATS lobectomy for stage I NSCLC but interestingly no difference for IL-8 and IL-10
(Nagahiro et al., 2001). The reason for this discrepancy is unknown. Interestingly, the
reported IL-6 levels in Nagahiro's study were much lower than those described here or
in other studies. Since IL-6 release is proportionately higher than IL-8 and IL-10
release, this may explain why they found no significant difference between surgery
types for these measured cytokines.
The body's response to surgical trauma is complex and involves the interaction of
various immunological and physiological systems including humoral and cellular
immunity, endocrine processes and neural stimulation (Walker et al., 2007).
Immunomodulating agents such as cytokines play an important role in cellular
messaging and the inflammatory cascade in addition to chemokines, growth factors,
lipid and complement. Previous studies of thoracic surgical patients have described an
association between elevated post-operative IL-6 and the systemic inflammatory
response syndrome (SIRS) (Takenaka et al., 2006) and between post-operative serum
IL-6/IL-8 and post-operative sepsis (Yamada et al., 1998). IL-6 is indeed known to
generate pyrexia, activate the hypothalamic pituitary axis and influence the hepatic
acute-phase response (Raeburn et al., 2002). However, there are many such proteins
released following surgical trauma with immunoregulatory roles. The requirement for a
delicately regulated balance between pro- and anti-inflammatory responses to
pathological insults is well described (Hotchkiss et al., 2003), and the implication is that
dysregulation of this balance may result in adverse outcomes.
It is important to appreciate that the presence of malignancy per se may also influence
cytokine release. Thus, baseline measurements of IL-12, TNF-a and IL-6 were
marginally higher in pre-operative lung cancer patients compared to an age-matched,
mixed gender control group (Table 3.7), suggesting an underlying pro-inflammatory
state in cancer patients. Higher serum cytokine levels in lung cancer patients have
previously been reported for example, TNF-a (Atwell et al., 1998) and IL-6 (Koh et al.,
2012).
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One important limitation of the comparison between lung resection performed via
VATS and thoracotomy in this study is that patients were not randomised into either
group. Surgery was performed whenever possible utilising the VATS approach. VATS
targeted early stage peripheral lung tumours. Thus, there were significantly more
adenocarinomas in the VATS groups compared to more squamous cell carcinomas in
the thoracotomy group (Table 3.2). Further, there were more stage IA tumours in the
VATS group (Table 3.3). Moreover, the actual operation performed differed between
the groups: the VATS group included lobectomy and segmentectomy whereas sleeve
resections, a chest wall resection and two pneumonectomies were performed in addition
to lobectomy in the thoracotomy group (Table 3.4). The impact of these details on the
inflammatory response is uncertain. Although the numbers were small, no significant
differences in serum cytokines were found when comparing lobectomy via thoracotomy
and other lung resections via thoracotomy. Despite the lack of randomisation, the
groups were well matched in terms of age and BMI (Table 3.1). More males however
were in the thoracotomy group and there was a non-significant trend for higher FEVi in
the VATS group together with a non-significant higher Thoracoscore.
It may also be a criticism that three patients in the thoracotomy group underwent initial
video-thoracoscopic inspection whereupon VATS resection was deemed technically
inappropriate leading to conversion to conventional thoracotomy. These operations
would have been slightly longer than if thoracotomy was performed from the outset,
with a potential, albeit small, impact on the inflammatory response. The conversions
however took place relatively soon after surgery commenced and the study was
designed to compare the VATS approach with thoracotomy.
VATS resection was associated with higher levels of serum albumin (Figure 3.7).
Serum albumin, produced by the liver, is reduced as part of the acute phase response
and is thus a 'negative' acute phase protein (Ritchie et al., 1999). This is thought to
allow amino acids to be used for producing positive acute phase proteins more
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efficiently. The lower levels are consistent with a reduced systemic inflammatory
response after VATS resection although were higher pre-operatively as well in the
VATS group. Low pre-operative serum albumin has been previously associated with
post-operative complications after lung resection (Amar et al., 2007 and Ferguson et al.,
2008). Post-operative hypoalbuminaemia has also been associated with poorer surgical
outcomes in off-pump coronary artery bypass surgery (Lee at al., 2008).
The clinical relevance of the reduced serum inflammatory response with VATS lung
resection is currently unclear. There is growing evidence that reduced post-operative
inflammation may lead to less peri-operative morbidity (Amar et al., 2007 and Shaw et
al. 2005) and certainly I have demonstrated heightened immune responses are
associated with post-operative pneumonia. However, no significant difference was
found in post-operative complications between the two surgical groups in this relatively
small study. Theoretically, reduced peri-operative immunosuppression with VATS
should lead to reduced risk of metastasis and recurrence. A meta-analysis found a
reduced systemic recurrence rate and improved 5-year mortality rate with VATS (Yan
et al., 2009). A more recent meta-analysis confirmed these findings in stage I lung
cancer (Li et al., 2012). The only other meta-analysis published on the subject also
found reduced mortality when non-randomised studies were included (Cheng et al.,
2007). A recent study linked higher IL-6 levels on day 1 post-operatively with a higher
risk of early post-operative recurrence, even if the resection was considered complete
(Kitaet al., 2011).
Ideally, a large multi-centre randomised controlled trial would be conducted measuring
immune function, short- and long-term morbidity and mortality after lobectomy via
VATS and thoracotomy. Such a study is unlikely to happen however due to the expense
and logistics of measuring immune function as well as the difficulty of established
VATS centres randomising patients into a thoracotomy group, with patient preference
highly likely to be in favour of the minimally invasive approach.
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BALF
BAL was used in this study to determine acute inflammatory responses to surgery at a
local, pulmonary level. Previous studies have described an increase in pulmonary
inflammation early in the course of thoracic surgery using serial BAL (Schilling et al.,
2005, Zingg et al., 2010 and Breunig et al., 2011). While informative, these studies are
confounded by the low volumes of saline instilled, reducing sample quality (Haslam et
al., 1999) and the close proximity of the pre- and post-operative BAL sampling
protocols. BAL itself is known to induce a brisk inflammatory response, recovering by
approximately 72 hours, which may impact on specimens obtained by repeated local
sampling (Von Essen et al., 1991, Huang Y-C et al., 2006 and Terashima et al., 2001).
Nevertheless, a separate study conducted by myself with seventeen patients, confirmed
that in the context of surgery, BAL does not induce a significant additional systemic
inflammatory response (appendix).
The pre-operative sample in this study was taken before mediastinoscopy (after
induction of anaesthesia) from the contra-lateral lung to the tumour, while the post¬
operative sample was taken at least one week later from another lobe of the contra¬
lateral lung, immediately after lung resection whilst the patient was still anaesthetised in
theatre (Table 3.11). The higher protein content (Figure 3.16), increased cellular content
(Figure 3.15 and Table 3.12) and cytokine composition (Figure 3.17) confirm that the
lung contralateral to the operated tumour is inflamed immediately after thoracic surgery.
This early pro-inflammatory effect is most likely attributable to one lung ventilation,
used in all patients in this study, and previously shown to induce inflammatory effects
in the lung (Moloney et al., 2004). OLV may result in inflammation due to high FiC>2,
leading to the generation of ROS, high tidal volumes and pulmonary capillary stress
failure due to more pulmonary artery blood entering the non-collapsed lung (Baudouin,
2003). One study demonstrated reduced levels of TNF-a and sICAM-1 in the ventilated
lung after thoracic surgery in patients ventilated with a tidal volume of 5mls/kg
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compared with lOmls/kg (Schilling et al., 2005). Others have found no difference in
pulmonary cytokines when using lower tidal volumes (Wrigge et ah, 2004) although
this study was based on tracheal aspirates rather than BAL which are less reflective of
alveolar inflammation. Certainly, numerous animal studies and clinical trials have found
ventilation with tidal volumes slightly above physiological levels can rapidly cause
acute lung injury (Dos Santos et ah, 2000).
The higher protein and cellular content observed post-operatively are consistent with
earlier published studies in patients undergoing thoracic surgery. Schilling et ah
performed BAL immediately before major thoracic surgery, including lung resection,
and at two time points after surgery from the dependent, ventilated lung (Schilling et ah,
2005). The total number of cells, protein and albumin counts all increased after surgery.
Schilling et ah also found higher levels of IL-8 post-operatively which has been
confirmed in the present study together with the work of Cree et ah and Zingg et ah in
oesophagectomy patients requiring one-lung ventilation (Cree et ah, 2004 and Zingg et
ah, 2010). IL-8 is an important chemotactic peptide primarily for neutrophils as well as
other granulocytes, inducing physiological responses such as phagocytosis. Levels in
BAL have been shown to be increased in a range of pathological processes including
ARDS, sepsis and multi-organ failure (Schuttte et ah, 1996). Indeed, although
neutrophils have beneficial anti-microbial effects they may prove detrimental to the host
with release of toxic products including elastase, leukotrienes and free radicals into the
alveolar space (Boutten et ah, 1996).
No patient developed clinical ALI/ARDS in this study. The only pulmonary parameter
associated with subsequent development of pneumonia was a relatively high pre¬
operative leucocyte count in BALF, indicating perhaps a pro-inflammatory tendency or
underlying subclincial infection/colonisation. Importantly, no relationship was
demonstrated between BALF IL-8 levels and post-operative pneumonia in the present
study, with BAL sampled immediately post-operatively. Whether differences emerge at
24hrs or 48hrs post-operatively would be an interesting enquiry. IL-8 and IL-ip have
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previously been shown to be important in diagnosing ventilator-associated pneumonia
in non-surgical, critically ill patients (Conway Morris et al., 2010).
Higher levels of pro-inflammatory IL-6, IL-1(3 and a small increase in anti¬
inflammatory IL-10 was also found in this study. IL-6 was found to be increased in the
non-operated lung of lung cancer patients by Breunig et al. together with anti¬
inflammatory IL-1RA (Breunig et al., 2011). This group also analysed BAL from the
operated lung in the same patient and found, perhaps unsurprisingly, higher IL-6 levels
in the operated lung. Indeed, handling and dissection of lung tissue together with
stapling devices across lung, bronchus and vascular tissue is likely to induce an acute
inflammatory response. Interestingly, in oesophagectomy patients, where direct lung
trauma to the non-ventilated lung is avoided, BAL cytokine inflammatory responses are
greater in the dependent, ventilated lung (Zingg et al., 2011).
No change in TNF-a was found in this study which contrasts with the findings of
Schilling et al. who found an increase in TNF-a together with a reduction in IL-10 post¬
operatively. The reason is unknown although may be related to differences in BAL
sampling methodology. This study also found no significant differences in any BALF
analysis between VATS and thoracotomy patients. This may be explained by the fact
that samples were taken from the non-operated lung and both groups of surgical patients
underwent standardised OLV.
Cellular Immune Responses
Lung resection was associated with a monocytosis (Figure 3.5B) due to an increase in
classical and intermediate monocytes in peripheral blood (Table 3.10), with no
significant difference identified between VATS and thoracotomy. Similar numerical
changes have been described after stroke (Urra et al., 2009) with a relative expansion in
intermediate monocytes and relative reduction in non-classical monocytes. A relative
reduction in non-classical monocytes has also been described following coronary artery
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bypass surgery in on- and off-pump surgery suggesting the effect was due to surgery
and not the cardiopulmonary bypass machine (Wehlin et ah, 2005).
Conversely, septic patients have been shown to expand the non-classical pool of
monocytes (Fingerle et ah, 1993) which are characterised by higher MHC II expression
and higher production of TNF-a after stimulation with Toll-like receptor ligands
(Ziegler-Heitbrock et ah, 2010). A host of other inflammatory and infectious diseases
are also associated with an expansion in the non-classical pool of monocytes including
atherosclerosis, Kawasaki disease and bacterial infections (Ziegler-Heitbrock, 2007).
The last blood sample in this study was taken at 48hrs and it is tempting to speculate
that the expansion in the intermediate pool could eventually expand the non-classical
pool, as seen in septic patients (Fingerle et ah, 1993). There was however no association
between post-operative pneumonia and changes in monocyte subset populations.
The pattern of increased LPS-induced cytokine secretion from monocytes post¬
operatively (Figure 3.12) is broadly similar to that described in a smaller study of
mononuclear cells from (non-thoracic) surgical patients (Cabie et ah, 1992), though we
did not observe the increase in IL-ip described in that study. Release of the anti¬
inflammatory cytokine IL-10 from monocytes was initially increased, but was blunted
by 48 hours, implying a net pro-inflammatory response of monocytes by that time. The
novel finding that enhanced early post-operative monocyte responsiveness maps to
increased risk ofpost-operative pneumonia (Table 4.7) suggests a potentially important
place for the monocyte in pneumonia pathogenesis. Certainly, it has been shown that in
established sepsis, there is down-regulation of monocyte HLA-DR expression and
reduced ability to produce TNF-a in response to LPS (Docke et ah, 1997).
Interestingly, reduced IL-12 release from LPS-stimulated monocytes retrieved pre-
operatively provided another strong association with later pneumonia. In mice, IL-12
has been shown to be protective against pneumonia induced by Klebsiella pneumoniae
(Greenberger et ah, 1996) and Pneumocystis carinii (Ruan et ah, 2008). Conversely, it
132
appears to impair host defence against Mycoplasma pneumoniae (Salvatore et al.,
2008). These findings compare with those of Hensler et al. who noted reduced IL-12
release from LPS-stimulated monocytes in patients progressing to post-operative sepsis
after major elective gastrointestinal surgery (Hensler et al., 1998). It is important to note
that I did not find surgery to significantly impact on IL-12 levels and that the
association with pneumonia was only apparent with pre-operative levels of the cytokine.
Lower levels of IL-10 production from monocytes stimulated with LPS were found with
VATS surgery at 6 hours post-operatively indicating less disturbance of peri-operative
immunity (Figure 3.12G). Nevertheless, no other differences were found with the other
measured cytokines produced ex-vivo from monocytes.
It is noteworthy that there were relatively high levels of IL-8 in normal monocyte
cultures (non-LPS) from surgical patients and healthy controls (Table 3.8). Positive
selection with anti-CD 14-labelled microbeads should not lead to signal transduction
since the essential co-receptors, such as TLR-4 and MD-2 are absent (Kitchens, 2000).
The cells were however cultured with patient serum from the relevant time point in
order to simulate the in vivo cytokine environment in which the cells would normally
function. This would have influenced cytokine production although doubtful to any
significant extent in comparison to LPS, particularly in the control group.
While monocytes generally displayed a pro-inflammatory phenotype after lung
resection, blood neutrophils, although increased in number (Figure 3.5A), were
associated with a minor reduction in phagocytic capacity for zymosan (Figure 3.11).
There was a small increase in E. Coli phagocytosis at 48 hrs post-operatively although
no significant overall change post-operatively on ANOVA modelling. A small, but
statistically significant, reduction in phagocytic capacity has also been described after
abdominal surgery (Kawasaki et al., 2007). It seems unlikely that the small reduction in
neutrophil phagocytosis was clinically important, as there was no association with post¬
operative pneumonia (Figure 4.8). In previous studies in patients admitted to the ICU it
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was shown that impaired neutrophil phagocytosis was associated with increased risk of
subsequent ICU-acquired infection, but the level of phagocytic impairment was far
greater in that cohort (Conway Morris et al., 2011).
No difference in post-operative neutrophil phagocytic capacity was found between
VATS and thoracotomy patients. Previous studies have shown that minimally invasive
surgery may affect cellular immunity less than conventional open surgery. Craig et al.
showed ROS in neutrophils increased post-operatively in thoracotomy but not VATS
patients although actual phagocytosis was not assessed (Craig et ah, 2001). All patients
developed a relative blood lymphopenia post-operatively (Figure 3.5B) but we did not
detect any significant difference between the surgical groups consistent with previous
research (Leaver et ah, 2000). Previous studies have shown reduced suppression of CD4
T cells at two days after VATS resection compared with thoracotomy and natural killer
lymphocytes at seven-days post-operatively (Craig et ah 2001).
Exhaled Nitric Oxide
This study found a trend for reduced FENO levels after lung resection which reached
significance at 48hrs post-operatively (Figure 3.20). The overall median reduction was
small in the order of a couple of parts per billion. The accuracy of measurements was
confirmed using two devices, a chemiluminescence analyser and a smaller, portable and
cheaper electrochemical sensor. There was excellent concordance of measurements
between the devices at the standardised flow rate of 50mls/second (Figures 3.18 and
3.19), which is consistent with a previous published report in asthmatic patients
(Menzies et ah, 2007).
Clearly a proportion of lung tissue has been removed which would contribute to this
reduction, assuming there was no complete bronchial obstruction by tumour of the
affected lung/ lobe. However, the contribution of alveolar nitric oxide to total exhaled
nitric oxide is usually small. Indeed, alveolar nitric oxide was calculated using variable
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exhaled breath flow rates and the principles of the two-compartment model of airway
dynamics (Pietropaoli et al., 1999). Essentially, the model divides the airways into two;
the lower, alveolar airways and upper, conducting airways. It is known that exhaled NO
increases as expiratory flow rates fall. This phenomenon is due to mixing between the
lower and upper airways; at fast exhalations alveolar nitric oxide makes a large
contribution to total nitric oxide whereas at slow exhalations NO from the conducting
airways predominates. Equations describing this mixing, together with the measurement
of total exhaled nitric oxide at different expiratory flow rates, allowed the contribution
of the lower and upper airways to be calculated. There was no significant overall
change in alveolar nitric oxide (Figure 3.21) implying the small overall reduction
observed was due to changes elsewhere. The other confounding variable however was
air leakage post-operatively which would have impacted on readings obtained by the
chemiluminescent analyser. Air leak was present, certainly early post-operatively, in the
majority of patients.
It may also be a criticism that the maximal exhaled flow rate was 150mls/sec in this
study which is lower than that used in the Pietropaoli paper. However, this was the
highest practical flow rate achievable in the majority of patients presenting for lung
cancer surgery; patients generally had impaired lung function pre-operatively together
with discomfort and air leakage from the lung post-operatively. The flow rates adopted
however were in line with the guideline of >100mls/sec for high flow and <50mls/sec
for low flow (ATS, 2005).
If it is accepted that exhaled nitric oxide is reduced, potential mechanisms, in addition
to air leakage and removal of lung tissue, include down-regulation of constitutive NOS
expression, reduced ability to induce NOS2 by inflammatory cytokines and
consumption reactions, for example, NO and superoxide forming the potent
peroxynitrite (Kobzik L, 2009). Indeed, activated neutrophils, sequestered to the lung in
acute inflammation, release superoxide (Baldwin et al., 1986). Further, post-operative
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perialveolar haemorrhage would increase NO-haemoglobin binding, reducing exhaled
nitric oxide (Brett et al., 1998).
No patients in this study developed clinical ALI/ARDS. Brett and Evans showed
significantly lower levels of exhaled nitric oxide in intubated patients with established
ARDS compared with a control group of intubated patients prior to cardiac surgery
(Brett et al., 1998). Other groups have shown exhaled NO to be reduced after
cardiopulmonary bypass surgery (Ishibe et al., 2000 and Cuthbertson et al., 2002) as
well as after lung transplantation (Marczin et al., 1997). The reduction in NO found in
this study after lung resection is therefore consistent with the findings of these other
forms of ischaemia-reperfusion injury and lung injury. Studies evaluating exhaled nitric
oxide post-operatively following lung resection are sparse. One paper examined exhaled
nitric oxide levels in patients undergoing thoracic surgery with one-lung ventilation
(Minami Y et al., 2003). Using an online system in intubated patients, they found that
exhaled nitric oxide levels returned to baseline after releasing one-lung ventilation
(which had been in place for approximately 3hours). In contrast, the measurements used
in this study were from spontaneously breathing, non-intubated patients without the
upper conducting airways excluded by an endotracheal tube. Further, the first post¬
operative measurement of exhaled nitric oxide in this study was 6hrs post-operatively,
when inflammatory changes may have had more time to establish.
The clinical implications of the apparent trend for reduced exhaled nitric oxide post-
lung resection are unclear. There was no significant difference in exhaled nitric oxide
levels in the early post-operative period between patients developing pneumonia or not
(Figure 4.13). This is consistent with a study in medical critical care patients which
found that early exhaled nitric oxide was not a useful biomarker for later pneumonia
(Tadie et al, 2010). Interestingly however nasal NO was found be moderately predictive
for ventilator associated pneumonia. A preliminary study suggested an association
between different NO patterns and clinical outcome after lung transplantation (Marczin
et al., 1997). Others have found elevated levels in patients with acute rejection after
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lung transplantation (Silkoff et al., 1998). These findings have not however been
confirmed or found real clinical utility.
No statistically significant differences were found at baseline between exhaled NO in
patients and an age matched group of healthy controls although there did appear to be a
tendency for higher levels in controls (Table 3.13). The reason for the relatively higher
levels in controls is unknown although it is tempting to implicate smoking status.
Exhaled nitric oxide levels have been shown to be up to 50% lower in smokers
compared with non-smokers (Kharitonov et al., 1995). The groups were well matched
in terms of current smoking status (Table 3.6) however there were more lifelong non-
smokers in the control group compared with ex-smokers in the patient group. It is also
known that ex-smokers have lower exhaled NO levels than non-smokers (Malinovschi
et al., 2006). Previous work comparing exhaled nitric oxide of lung cancer patients and
healthy controls showed higher levels in lung cancer patients from Taiwan (Liu et al.,
1998). However, it is important to note that over 70% of the lung cancer patients were
non-smokers (20/28) compared with 32% in this study. Further, the exhaled flow rate
used was higher at 200mls/sec than the now standard 50mls/sec adopted for this study.
Novel Biomarkers
Overall, a relatively high baseline number of leucocytes in both the circulation and the
alveoli, and a relatively high responsiveness of circulating monocytes, may leave the
patient susceptible to pulmonary inflammation post-operatively. It is tempting to
speculate that patients with a relatively pro-inflammatory tendency are susceptible to
post-operative infection, but this hypothesis requires further investigation. While these
findings enhance understanding of the biology and possible clinical implications of the
innate immune response to thoracic surgery, interpretation of the data requires some
caution. Thus, although the clinical characteristics of our cohort are broadly
representative of patients undergoing thoracic surgery, the associations with post¬
operative pneumonia require confirmation. Further, we cannot be certain of the
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aetiology of the pneumonia in this study, as our definition did not require
microbiological confirmation, and CXR does not have optimal sensitivity and
specificity for the detection of pneumonia (Syrjala et al., 1998). However, our diagnosis
of pneumonia was pre-defined and CXRs were interpreted by a pulmonary radiologist
blinded to other study results. Eight of the 14 patients also had positive sputum culture
as part of their routine clinical care. We can be relatively confident that our
'pneumonia' patients had alveolar inflammation that would be recognised as such by
most clinicians. It is also important to note that most of the patients in this study had
lung cancer and a burden of tobacco exposure, both of which can influence innate
immunity, together with medications including statins. Finally, as with all functional
studies using neutrophils and monocytes, we cannot be certain that the ex vivo
monocyte responsiveness and neutrophil phagocytosis data are representative of
biological activity in vivo.
Conclusion
In conclusion, this study provides a unique and comprehensive insight into the early and
profound effects that major thoracic surgery has on innate immune function. Surgery
induces systemic cytokine release and a blood leucocytosis due to neutrophilia and
monocytosis. In addition, a relative blood lymphopenia occurs. There is an expansion in
the classical and intermediate monocyte pool with an increase in the responsiveness of
blood monocytes to LPS together with minor impairment of the phagocytic capacity of
blood neutrophils. BALF from the contralateral lung reveals evidence of early acute
inflammation and exhaled nitric oxide levels are generally reduced post-operatively.
VATS is associated with reduced increments in pro-inflammatory serum cytokines IL-6
and IL-8 and the anti-inflammatory IL-10. Further, VATS is associated with a
significantly lower reduction in serum albumin. Ex-vivo stimulation of isolated
monocytes with LPS revealed lower levels of anti-inflammatory IL-10 six hours post¬
operatively in VATS patients.
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Post-operative pneumonia occurred in 35% of patients. Pre-operatively, relatively high
numbers of leucocytes in blood and BALF are associated with post-operative
pneumonia, as is relatively low secretion of IL-12 from LPS-stimulated monocytes. In
the early post-operative phase, a hyper-secretory phenotype in LPS-stimulated
monocytes is associated with later development of pneumonia. Together, these findings
suggest that innate immune status may influence the pathogenesis of post-operative
pulmonary inflammation and could potentially aid stratification of post-operative risk in
the future. Further dissection of the innate immune response may ultimately suggest
plausible targets for the prevention of post-operative pneumonia. Finally, these data add
to the case that VATS lobectomy should be the surgical treatment strategy of choice in
early stage lung cancer.
Future Research
This study has linked post-operative pneumonia with host innate immune function,
specifically pre-operative leucocyte counts in blood and BALF and early post-operative
monocyte responses to LPS. These findings warrant further investigation in a larger
cohort of patients across a range of centres. Determining the mechanisms through which
these factors are linked to post-operative pneumonia, particularly monocyte hyper-
responsiveness, would be important to target prophylactic/therapeutic measures.
Ultimately, randomisation of prophylactic/therapeutic measures such as more prolonged
courses of peri-operative antibiotics or immune modulators such as steroids in those
patients stratified as high-risk may reduce the incidence of post-operative pneumonia.
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Appendix
Abstract presented at The Society for Cardiothoracic Surgeons of Great Britain
and Ireland, Annual Meeting, Brighton, March 2013. Awarded the Society
Thoracic Medal.
Jones RO, Brittan M, Anderson NH, Conway Morris A, Murchison JT, Simpson AJ,
Walker WS. Cellular Innate Immune Responses to Lung Resection Predict Post-
Operative Pneumonia.
OBJECTIVE: Post-operative pneumonia is an important cause ofmorbidity and
mortality following lung cancer resection. We hypothesise that early changes in innate
immune parameters may help identify patients at greatest post-operative risk and
potentially identify future therapeutic strategies.
METHODS: Patients undergoing lung resection for suspected bronchogenic carcinoma
were recruited. Blood was sampled pre-operatively and at 6, 24 and 48 hours post¬
operatively. Neutrophil phagocytic capacity, monocyte subset changes and cytokine
release from lipopolysaccharide (LPS)-stimulated monocytes were quantified in all
patients at all time points. Bronchoalveolar lavage (BAL) was performed in the
contralateral lung pre- and post-operatively. Screening for pneumonia was performed
72-hours post-operatively.
RESULTS: 40 patients were studied of which 14 (35%) developed post-operative
pneumonia. Pre-operatively, a blood neutrophil count above 5.04x109/L had a relative
risk (RR) for pneumonia of 3.3 (95% confidence interval (CI95) 1.1-10.1), and a BAL
cell count of greater than 1.04xl05/ml had a RR of 3.4 (CI95 1.3-9.0), whilst LPS-
stimulated monocyte secretion of IL-12 of less than 0.15 pg/ml/pg protein had a RR of
3.0 (CI95 1.2-7.3). At 24 hours post-operatively, LPS-stimulated release from
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monocytes of IL-10 greater than 1.99 pg/ml/pg protein (RR 4.1, CI95 1.3-12.3) and IL-6
greater than 414 pg/ml/pg protein (RR 3.1, CI95 1.2-8.1) were predictive of pneumonia.
CONCLUSION: Relative pre-operative leucocytosis and relatively brisk monocyte
responsiveness to stimulation in the early post-operative period are associated with
development of pneumonia. These findings suggest novel markers for post-operative
pneumonia and a role for monocytes in its pathogenesis.
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Further to your recent presentation at our annual meeting in Brighton, I am writing
to congratulate you on your achievement in winning the Society Thoracic medal for
your presentation entitled Cellular Innate Immune Responses to Lung Resection
Predict Post-Operative Pneumonia.
In recognition of your achievement, it is our pleasure to invite you on behalf of the
President and Executive Committee to attend next year's annual dinner in
Edinburgh where you will be officially presented with your prize. I will send you
further details nearer the time
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Abstract presented at 26th EACTS Annual Meeting, Barcelona, Spain, 29th
October 2012.
Jones RO, Anderson NH, Murchison JT, Brittan M, Simon EJ, Casali G, Simpson AJ,
Walker WS. Innate Immune Function Following Major Lung Resection For
Bronchogenic Carcinoma via Video-Assisted Thoracoscopic Surgery and Thoracotomy.
Interactive Cardiovascular and Thoracic Surgery 2012; 15 (2): S82.
Objectives: To prospectively compare the innate immune response of patients
undergoing lung resection for bronchogenic carcinoma via Video-Assisted
Thoracoscopic Surgery (VATS) and thoracotomy. Improved understanding of peri¬
operative inflammatory responses may help elucidate immediate post-operative
complications such as pneumonia and ALI/ARDS and may ultimately lead to
improvements in patient survival.
Methods: Lung resection for suspected bronchogenic carcinoma was performed with a
VATS approach or thoracotomy. Bronchoalveolar lavage (BAL) was conducted in the
contra-lateral lung prior to staging bronchoscopy and mediastinoscopy and innnediately
after lung resection. Blood and exhaled nitric oxide was sampled pre-operatively and at
6-, 24- and 48-hours post-operatively.
Results: Forty patients were included in the study (26 VATS, 14 thoracotomy). There
was a lower systemic cytokine response from VATS patients compared with
thoracotomy for serum IL-6 (ANOVA p=0.026), IL-8 (ANOVA p=0.018) and IL-10
(ANOVA p=0.047). A trend for lower post-operative blood neutrophil counts in VATS
patients fell just short of significant (ANOVA p=0.054). VATS surgery resulted in a
lower fall in serum albumin post-operatively (ANOVA p=0.001). Lower levels of IL-10
were produced by lipopolysaccharide (LPS)-stimulated blood monocytes from VATS
patients compared with thoracotomy at 6 hrs post-operatively (geometric mean ratio
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1.16 95% CI 1.08-1.33 p=0.011). No statistically significant difference in the neutrophil
phagocytic capacity, lymphocyte count, monocyte count or monocyte subset count was
found between the surgical groups (ANOVA p>0.05). No statistically significant
differences in BAL fluid parameters were found. Exhaled nitric oxide levels fell post¬
operatively which reached statistical significance at 48hrs (geometric mean ratio 1.2
95% CI 1.02-1.46 p=0.029). There was no significant difference found between patients
undergoing resection via VATS or thoracotomy (ANOVA p=0.331).
Conclusion: Greater pro- and anti-inflammatory responses are seen with lung resection
performed via thoracotomy compared with VATS. These data further support increased
use of VATS lobectomy techniques.
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Abstract presented at The British Thoracic Society (BTS), Winter Meeting,
London, 6 December 2012.
Jones RO, Murchison JT, Casali G, Simon EJ, Anderson N, Simpson AJ, Walker WS.
Bronchoalveolar Lavage Does Not Affect The Acute Inflammatory Response Following
Bronchoscopy and Mediastinoscopy. Thorax 2012; 67; (Suppl 2): A110.
Objective: Bronchoalveolar lavage (BAL) may be used to investigate acute
inflammation following thoracic surgery. However, BAL has previously been found to
induce an acute phase response in healthy and critically-ill patients complicating
research analysis (1,2). We sought to examine the impact of BAL in thoracic surgery
patients hypothesising that BAL would not lead to a significant additional acute
inflammatory response.
Methods: Seventeen patients undergoing lung cancer staging bronchoscopy and
mediastinoscopy were randomly assigned to have 220mls 0.9% NaCl BAL before
surgery (n=T0) or no BAL (n=7). Blood samples were taken pre-operatively followed
by 6 and 24 hours post-operatively. Exhaled nitric oxide (eNO) was also measured at a
flow rate of 50mls/sec at these times. All patients had a CXR at 24hrs and were
evaluated for evidence of SIRS using pre-defined criteria.
Results: IL-6 and CRP increased post-operatively peaking at 6hrs and 24hrs
respectively however there was no statistically significant difference between the
increase for BAL and non-BAL patients (p>0.05). There was no significant increase or
variation between the groups for IL-2, IL-4, IL-10, TNF-a or IFN-y (p>0.05). eNO
tended to decrease in the BAL group and increase in the non-BAL group at 6hrs
although there was no significant difference between the groups (p=0.167). Post¬
operative CXR atelectasis developed in 3 patients (2 BAL). One patient in each group
developed SIRS.
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Conclusion: BAL has minimal impact on acute inflammation following bronchoscopy
and mediastinoscopy. It may therefore be used to safely and reliably obtain samples for
research or microbiology purposes in thoracic surgery patients.
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